prednisolone has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 478 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma." | 7.75 | [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009) |
"Hypercalcemia in a 4-year-old boy with non-Hodgkin lymphoma treated with pamidronate is presented." | 7.69 | Childhood cancer and hypercalcemia: report of a case treated with pamidronate. ( Akyüz, C; Büyükpamukçu, M; Hazar, V; Kutluk, MT; Varan, A, 1997) |
"Six courses of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) or cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone (CHOEP) chemotherapy were recommended for first-line therapy of patients with nodal, intestinal or hepatosplenic T-cell lymphomas (evidence: low; recommendation: do, weak)." | 3.80 | SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. ( Barosi, G; Billio, A; Corradini, P; Gallamini, A; Marchetti, M; Pileri, S; Pimpinelli, N; Rossi, G; Tura, S; Zinzani, PL, 2014) |
" Toxic encephalopathy was diagnosed in 6 (10%) patients with acute leucosis treated by endolumbal administration of metotherxate, cytarabine and prednisolone (to prevent neuroleukemia) and in 2 (8%) patients with non-Hodgkin lymphomas." | 3.78 | [Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas]. ( Zyrina, GV, 2012) |
"A 49-year-old-man, a healthy carrier of hepatitis B virus (HBV), received chemotherapy with a rituximab/cyclo- phosphamide/doxorubicin/vincristine/prednisolone (R-CHOP) regimen for non-Hodgkin's lymphoma." | 3.75 | [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma]. ( Kitada, N; Kobayashi, M; Kondo, M; Mori, A; Morita, S; Okamoto, T; Tsuji, T; Watari, M; Yoshioka, M, 2009) |
"We describe a patient with non-Hodgkin's lymphoma treated with a chemotherapy regimen (which included bleomycin, prednisolone and low-dose methotrexate) who developed cutaneous non-caseating granulomas." | 3.70 | Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma. ( Cream, JJ; Farrell, AM; Francis, N; Henry, K; Mitchell, DN; Newlands, ES; Woodrow, D, 1999) |
"Hypercalcemia in a 4-year-old boy with non-Hodgkin lymphoma treated with pamidronate is presented." | 3.69 | Childhood cancer and hypercalcemia: report of a case treated with pamidronate. ( Akyüz, C; Büyükpamukçu, M; Hazar, V; Kutluk, MT; Varan, A, 1997) |
" Four case reports are presented; 3 lymphomas and 1 multiple myeloma that developed, in heart transplant recipients receiving triple-drug immunosuppression: azathioprine, cyclosporine and prednisolone." | 3.68 | [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. ( Burtin, P; Guerci, AP; Lederlin, P; Mattei, S, 1992) |
"Prednisolone (PRED) was given at the fixed dose of 60 mg/m(2) (IV or orally) on days 1-5." | 2.79 | A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial. ( Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P, 2014) |
" Patients with previously untreated aggressive NHL were randomized to receive either eight cycles of (R)CHOP given every 3 wk or (R)CHOP combined with gemcitabine [Gem-(R)CHOP]." | 2.76 | Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54). ( Aurer, I; Baila, L; Eghbali, H; Fortpied, C; Khaled, HM; Raemaekers, J; van der Maazen, RW, 2011) |
"Grade 3 and 4 infections occurred four times more frequently in the dose-dense arm." | 2.75 | Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma. ( Chott, A; Drach, J; Fridrik, MA; Geissler, D; Greil, R; Hausmaninger, H; Krieger, O; Lang, A; Michlmayr, G; Oberaigner, W; Ulsperger, E, 2010) |
"Treatment with etoposide also evolved as a prognostic factor because the risk of CNS failure was significantly reduced after CHOEP (P=0." | 2.73 | Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S, 2007) |
"3HCL, a potent inhibitor of P-glycoprotein (P-gp), when administered orally alone and in combination with the CHOP regimen in patients with untreated non-Hodgkin's lymphoma and to determine whether zosuquidar." | 2.73 | Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma. ( Bouafia, F; Burgess, M; Dumontet, C; Morschhauser, F; Sloots, L; Zinzani, PL, 2007) |
"Etoposide levels were determined by high-performance liquid chromatography (HPLC), and pharmacokinetic parameters were calculated with the TOPFIT computer program." | 2.73 | Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas. ( Ehninger, G; Friedrichsen, K; Haenel, M; Kroschinsky, FP; Mueller, J; Prondzinsky, R; Pursche, S; Schleyer, E, 2008) |
"Prednisolone 40 mg/m(2) was administered daily for three 14-day periods during weeks 1-2, 5-6 and 9-10." | 2.72 | Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma. ( Aoki, S; Hirano, M; Kohori, M; Miura, I; Niitsu, N; Okamoto, M, 2006) |
"Idarubicin is a 4-demethoxy-anthracycline analogue of daunorubicin that has proven activity in non-Hodgkin lymphoma, and has been reported to cause less cardiotoxicity." | 2.71 | Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. ( Burton, C; Cunningham, D; Hancock, B; Hoskin, P; Linch, D; Qian, W; Smith, P; Vaughan-Hudson, G, 2005) |
"Rituximab, a chimeric monoclonal antibody, produces response rates of up to 73% in patients with previously untreated indolent non-Hodgkin's lymphoma (NHL), and has high activity when combined with chemotherapy." | 2.71 | Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma. ( Christodoulou, C; Dimopoulos, M; Economopoulos, T; Fountzilas, G; Hamilos, G; Kalantzis, D; Nicolaides, C; Papageorgiou, E; Pavlidis, N, 2003) |
"Mitoxantrone is an anthracenedione, which is active in NHL and its toxicity profile may be more favorable than doxorubicin with respect to alopecia, mucositis and cardiotoxicity." | 2.71 | A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma. ( Angelopoulou, MK; Bourantas, KL; Christopoulos, G; Grigorakis, V; Kalmantis, T; Kokkinis, G; Korantzis, J; Michalis, E; Mihalakeas, I; Pangalis, GA; Papayiannis, A; Repousis, P; Roussou, P; Siakantaris, MP; Stamatellou, M; Stefanoudakis, E; Symeonidis, A; Vassilakopoulos, TP; Vrakidou, E, 2003) |
"CHOP-14 with the addition of rhG-CSF is safe and practicable in a large multicentre setting in patients aged 18-75 years." | 2.71 | Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A, 2003) |
" In this multicenter study, THP (pirarubicin)-COP (cyclophosphamide, vincristine, and prednisolone) was compared to two thirds dosage of full CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen with regard to both adverse events and efficacy." | 2.71 | Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma. ( Harada, M; Hotta, T; Kitamura, K; Masaoka, T; Masuda, M; Matsuda, T; Miura, AB; Miyazaki, T; Mizoguchi, H; Mori, M; Niho, Y; Saito, H; Shibata, A; Takaku, F, 2005) |
"Epirubicin is an agent with a lower incidence of cardiotoxicity and myelotoxicity compared with doxorubicin; and it is active in patients with non-Hodgkin's lymphoma (NHL)." | 2.70 | Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study. ( Alici, S; Basaran, M; Bavbek, ES; Camlica, H; Dogan O, O; Eralp, Y; Onat, H; Sakar, B; Tas, F; Yaman, F, 2001) |
" There were no toxic deaths." | 2.69 | Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation. ( Cavenagh, JD; Eden, AG; Hughes, A; Kelsey, SM; Lamont, A; McBride, NC; Mills, MJ; Newland, AC; Ward, MC, 1999) |
" The administration of G-CSF at a dosage of 5 micrograms/kg/day for 11 doses following CHOP resulted in an overall net cost of $Can1257." | 2.68 | Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma. ( Altmayer, C; Dranitsaris, G; Quirt, I, 1997) |
"However, leukocytopenia was observed in many patients despite combined use of G-CSF, suggesting the dose and administration method of THP should be studied further." | 2.68 | [Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma]. ( Nakayama, M; Niitsu, N; Umeda, M, 1997) |
" The mean bioavailability was 14% for chlorambucil, 21% for phenylacetic acid mustard, and 22% for prednisolone, when given as prednimustine, compared to the administration of free compounds in stoichiometrically equivalent doses." | 2.67 | Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration. ( Loos, U; Malek, M; Musch, E; Riedel, E, 1991) |
" However on multivariate analysis only the presence of bulky disease and of B symptoms were independent adverse factors for response and for survival." | 2.67 | EPIC: an effective low toxicity regimen for relapsing lymphoma. ( Ashley, S; Catovsky, D; Cunningham, D; Gore, ME; Hickish, T; Mansi, J; Nicolson, V; Roldan, A; Smith, IE, 1993) |
"Epirubicin is an effective agent when used in combination chemotherapy in both low grade and high grade lymphoma with less toxicity than doxorubicin." | 2.66 | Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma. ( Al-Ismail, SA; Gough, J; Whittaker, JA, 1987) |
"In the chronic lymphocytic leukemia group, 3/4 have had benefit." | 2.64 | Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087). ( Aungst, CW; Mittelman, A; Murphy, GP, 1975) |
"Mitoxantrone has a broad anti-tumour activity including lymphoma with potentially less cardiotoxicity than doxorubicin, which may be of particular importance in elderly patients." | 2.44 | CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis). ( Ahlbom, A; Anders, A; Andersson, T; Björkholm, M; Eva, O; Magnus, B; Ösby, E; Tomas, A, 2008) |
"Although pemphigus vulgaris is not a common disease of the oral cavity, its potential to cause severe or life-threatening disease is such that the general dentist must have an understanding of its pathophysiology, clinical presentation and management." | 2.43 | Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris. ( Daley, T; Darling, MR, 2006) |
"Erythema nodosum is the most frequent clinicopathological variant of the panniculitides." | 2.42 | [Erythema nodosum association with malignant lymphoma]. ( Griniūte, R; Pileckyte, M, 2003) |
"A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported." | 2.40 | [Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998) |
"Although vomiting was not observed in the acute phase, nausea was seen in 22." | 1.48 | [Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)]. ( Hosono, N; Itoh, K; Matsuda, Y; Oiwa, K; Ookura, M; Tai, K; Ueda, T; Yamauchi, T, 2018) |
"Neutropenia was documented in 20 dogs (57%): 12 grade I to II, 8 grade III to IV." | 1.48 | Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas. ( Amores-Fuster, I; Blackwood, L; Finotello, R; Harper, A; Killick, DR; Maddox, TW; Mason, SL; Tanis, JB, 2018) |
"Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43." | 1.48 | Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan. ( Anwar, S; Faizan, M; Khan, S, 2018) |
"Postoperative pyoderma gangrenosum has been most commonly reported from breast and visceral surgery." | 1.46 | [Pyoderma gangraenosum after implantation of a shoulder endoprothesis]. ( Anderl, W; Domej, MA; Heuberer, PR; Pauzenberger, L, 2017) |
" This study aimed to assess the efficacy and toxicity of dose-adjusted CHOP alone or in combination with rituximab (R-CHOP) by examining the stem cell mobilization in NHL patients." | 1.42 | Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma. ( Gui, L; Han, X; He, X; Liu, P; Qin, Y; Shi, Y; Yang, J; Yang, S; Yao, J; Zhang, C; Zhang, S; Zhao, L; Zhou, P; Zhou, S, 2015) |
"Treatment with amphotericin B(AMPH-B) and flucytosine(5-FC) was initiated as diagnosis of cryptococcus meningitis." | 1.37 | Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review. ( Ainoda, Y; Fujita, T; Hirai, Y; Mori, N; Motoji, T; Shiseki, M; Shoji, T; Teramura, M; Totsuka, K; Yoshinaga, K, 2011) |
"Lentigines are characterized by brown macules developing due to increased proliferation of melanocytes in the dermoepidermal junction." | 1.36 | Generalized eruptive lentiginosis induced by chemotherapy. ( De, D; Dogra, S; Kanwar, AJ; Saikia, UN, 2010) |
"She was eventually diagnosed as having acute myeloblastic leukemia (AML; M0) with non-Hodgkin lymphoma (NHL)." | 1.35 | Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma. ( Horikoshi, A; Hosokawa, Y; Iriyama, N; Ishizuka, H; Kitoh, T; Sawada, S; Shiraiwa, H; Takei, K; Uenogawa, K, 2009) |
"Granulocytic sarcoma is an extramedullary tumor composed of immature granulocytic precursor cells." | 1.34 | Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report. ( Adil, SN; Khalid, S; Vaziri, IA, 2007) |
"BOOP was diagnosed and he responded well to oral prednisolone." | 1.33 | Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. ( Allen, D; Burke, E; Drake, M; Elborn, S; Gleadhill, I; Kettle, P; Macartney, C; Magee, N; Noone, P, 2005) |
"Gastrointestinal mucormycosis is a rare, often fatal, systemic infection found predominantly in immunocompromised patients." | 1.31 | Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma. ( Edmonson, R; Mir, N; Rashid, H; Yeghen, T, 2000) |
"One cat, with lymphosarcoma limited to a single mandibular lymph node, was treated using surgery alone and was cured." | 1.31 | Therapy for Australian cats with lymphosarcoma. ( Canfield, PJ; Foster, SF; Gabor, LJ; Malik, R; McCorkell, BE, 2001) |
"We describe two cases of interstitial lung disease in patients with non-Hodgkin's lymphoma who were treated with combination chemotherapy including mitozantrone." | 1.30 | Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy. ( Johnson, S; Nicholson, AG; Rule, S; Stone, R; Tighe, M; Tomlinson, J, 1999) |
"Four years and 4 months later, refractory anemia with excess of blasts (RAEB) with dup(11) (q21q23) x 2 developed in the patient and progressed to acute myeloid leukemia (AML-M5b)." | 1.30 | [Therapy-related MDS/leukemia carrying dup(11) (q21q23) with MLL gene tandem duplication]. ( Eguchi, M; Eguchi-Ishimae, M; Imanaka, F; Kamada, N; Takimoto, Y, 1998) |
"We treated three cases of interstitial pneumonitis (IP) in 26 elderly (> or = 65 years old) patients with non-Hodgkin's lymphoma (NHL) who received the same chemotherapeutic protocol including granulocyte colony-stimulating factor (G-CSF) administration." | 1.30 | Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma. ( Abe, T; Hasegawa, Y; Kamoshita, M; Kobayashi, T; Kojima, H; Nagasawa, T; Ninomiya, H; Ohtani, K, 1997) |
"Pneumonitis is a well recognized side effect of this drug, but occurs at low doses in the treatment of NHL." | 1.30 | Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma. ( Bloor, AJ; Marcus, RE; Seale, JR, 1998) |
"The history revealed an anaplastic anemia." | 1.29 | [Mycotic retrobulbar neuritis]. ( Kössling, S; Meier, P; Nenning, H; Penk, A, 1994) |
"Chylothorax is an accumulation of thoracic lymph or chyle in the pleural cavity." | 1.29 | Intrapleural bleomycin in the treatment of chylothorax. ( Aasebø, U; Norum, J, 1994) |
"Fever or/and clinical infection were observed in 4% and 14% of cycles." | 1.29 | Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte. ( Biron, P; Bordessoule, D; Coiffier, B; Gisselbrecht, C; Guerci, A; Herbrecht, R; Kerneis, Y; Lederlin, P; Reyes, F; Sebban, C; Tilly, H, 1996) |
"In stage III and IV Hodgkin's disease, for example, an age-adjusted COPP regimen may be adopted." | 1.28 | [Treatment of elderly patients with hematological malignancies]. ( Mizoguchi, H; Saito, H, 1992) |
"The survival of patients with diffuse lymphoma large cell type (DL) was better than those with other diffuse lymphomas." | 1.28 | [Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma]. ( Aotsuka, N; Asai, T; Endoh, N; Hirasawa, A; Hiruma, K; Igarashi, T; Nakamura, H; Oh, H; Wakita, H; Yoshida, S, 1990) |
"The use of azathioprine in ulcerative colitis is unclear." | 1.28 | The role of azathioprine in the management of ulcerative colitis. ( Axon, AT; Burke, DA; Foster, PN; Johnston, D; Lobo, AJ, 1990) |
" Combination of radiotherapy and chemotherapy can improve the survival rate, but the optimal dosage needs to be investigated further." | 1.28 | Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. ( Abe, M; Dodo, Y; Shibamoto, Y; Shima, N; Tsutsui, K; Yamabe, H, 1990) |
"Seventeen patients with non-Hodgkin's lymphoma (NHL) and 2 patients with Hodgkin's disease (HD) were treated by combination chemotherapy (COPP or CHOP), and then received 300 X 10(4) U of alpha-IFN daily for 14 days." | 1.27 | [A preliminary study of chemo-interferon therapy in malignant lymphoma]. ( Fukutani, H; Takeyama, H; Watanabe, E; Yano, K, 1987) |
"15 patients with malignant lymphomas (stage III B or IV) who had become resistant to previous combination chemotherapy were treated with DTIC." | 1.26 | Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations. ( Donner, L; Klener, P, 1977) |
"For patients with lymphosarcoma the average duration of complete remission was 26." | 1.26 | [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)]. ( Hiller, E; Schmülling, RM; Tigges, FJ; Waller, HD; Wilms, K, 1977) |
"A case of lymphosarcoma of the heart in a 10-year-old boy is presented." | 1.25 | Mediastinal lymphosarcoma simulating pericarditis. ( Berg, M; Eriksson, A; Wilander, E, 1975) |
"Necropsy revealed a reticulum cell sarcoma-microglioma of the brain." | 1.25 | Cerebral reticulum cell sarcoma after multiple renal transplants. ( Barnett, LB; Schwartz, E, 1974) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 110 (23.01) | 18.7374 |
1990's | 173 (36.19) | 18.2507 |
2000's | 154 (32.22) | 29.6817 |
2010's | 39 (8.16) | 24.3611 |
2020's | 2 (0.42) | 2.80 |
Authors | Studies |
---|---|
Ikeda, T | 1 |
Fujiwara, SI | 1 |
Nakajima, H | 1 |
Kawaguchi, SI | 1 |
Toda, Y | 1 |
Ito, S | 1 |
Ochi, S | 1 |
Nagayama, T | 1 |
Mashima, K | 1 |
Umino, K | 1 |
Minakata, D | 1 |
Nakano, H | 1 |
Morita, K | 2 |
Yamasaki, R | 1 |
Kawasaki, Y | 1 |
Ashizawa, M | 1 |
Yamamoto, C | 1 |
Hatano, K | 1 |
Sato, K | 1 |
Oh, I | 1 |
Ohmine, K | 1 |
Muroi, K | 2 |
Kanda, Y | 1 |
Maggen, C | 1 |
Dierickx, D | 1 |
Cardonick, E | 1 |
Mhallem Gziri, M | 1 |
Cabrera-Garcia, A | 1 |
Shmakov, RG | 1 |
Avivi, I | 1 |
Masturzo, B | 1 |
Duvekot, JJ | 1 |
Ottevanger, PB | 1 |
O'Laughlin, A | 1 |
Polushkina, E | 1 |
Van Calsteren, K | 1 |
Woei-A-Jin, FJSH | 1 |
Amant, F | 1 |
Domej, MA | 1 |
Pauzenberger, L | 1 |
Heuberer, PR | 1 |
Anderl, W | 1 |
Faizan, M | 1 |
Anwar, S | 1 |
Khan, S | 1 |
Oiwa, K | 1 |
Hosono, N | 1 |
Itoh, K | 6 |
Ookura, M | 1 |
Matsuda, Y | 1 |
Tai, K | 1 |
Ueda, T | 1 |
Yamauchi, T | 1 |
Tanis, JB | 1 |
Mason, SL | 1 |
Maddox, TW | 1 |
Blackwood, L | 1 |
Killick, DR | 1 |
Amores-Fuster, I | 1 |
Harper, A | 1 |
Finotello, R | 1 |
Hagemeister, F | 2 |
Rodriguez, MA | 2 |
Deitcher, SR | 1 |
Younes, A | 2 |
Fayad, L | 1 |
Goy, A | 1 |
Dang, NH | 1 |
Forman, A | 1 |
McLaughlin, P | 3 |
Medeiros, LJ | 1 |
Pro, B | 1 |
Romaguera, J | 1 |
Samaniego, F | 1 |
Silverman, JA | 1 |
Sarris, A | 1 |
Cabanillas, F | 2 |
Kiratli, H | 1 |
Tarlan, B | 1 |
Uzun, S | 1 |
Tanas, Ö | 1 |
Uner, A | 1 |
Maie, K | 1 |
Okoshi, Y | 1 |
Takaiwa, N | 1 |
Kurita, N | 1 |
Hasegawa, Y | 2 |
Homma, M | 1 |
Ishii, K | 1 |
Kohda, Y | 1 |
Chiba, S | 1 |
Limmer, S | 1 |
Eberle, N | 1 |
Nerschbach, V | 1 |
Nolte, I | 1 |
Betz, D | 1 |
Hiraishi, Y | 1 |
Iikura, M | 1 |
Kogure, Y | 1 |
Hirashima, J | 1 |
Izumi, S | 1 |
Sugiyama, H | 1 |
Corradini, P | 1 |
Marchetti, M | 1 |
Barosi, G | 1 |
Billio, A | 1 |
Gallamini, A | 1 |
Pileri, S | 2 |
Pimpinelli, N | 1 |
Rossi, G | 2 |
Zinzani, PL | 4 |
Tura, S | 3 |
Ahmad, AK | 1 |
Hui, P | 1 |
Litkouhi, B | 1 |
Azodi, M | 1 |
Rutherford, T | 1 |
McCarthy, S | 1 |
Xu, ML | 1 |
Schwartz, PE | 1 |
Ratner, E | 1 |
Olivier, G | 1 |
Clavert, A | 1 |
Lacotte-Thierry, L | 1 |
Gardembas, M | 1 |
Escoffre-Barbe, M | 1 |
Brion, A | 1 |
Cumin, I | 1 |
Legouffe, E | 1 |
Solal-Celigny, P | 1 |
Chabin, M | 1 |
Ingrand, P | 1 |
Colombat, P | 2 |
Delwail, V | 2 |
Knutson, SK | 1 |
Warholic, NM | 1 |
Johnston, LD | 1 |
Klaus, CR | 1 |
Wigle, TJ | 1 |
Iwanowicz, D | 1 |
Littlefield, BA | 1 |
Porter-Scott, M | 1 |
Smith, JJ | 1 |
Moyer, MP | 1 |
Copeland, RA | 1 |
Pollock, RM | 1 |
Kuntz, KW | 1 |
Raimondi, A | 1 |
Keilhack, H | 1 |
Tseng, YD | 1 |
Chen, YH | 1 |
Catalano, PJ | 1 |
Ng, A | 1 |
Curran, K | 1 |
Thamm, DH | 1 |
Shi, Y | 1 |
Zhou, P | 1 |
Han, X | 1 |
He, X | 1 |
Zhou, S | 1 |
Liu, P | 1 |
Yang, J | 1 |
Zhang, C | 1 |
Gui, L | 1 |
Qin, Y | 1 |
Yang, S | 1 |
Zhao, L | 1 |
Yao, J | 1 |
Zhang, S | 1 |
Elting, LS | 1 |
Xu, Y | 1 |
Chavez-MacGregor, M | 1 |
Giordano, SH | 1 |
Gupta, A | 1 |
Tse, L | 1 |
Vranovsky, A | 1 |
Ladicka, M | 1 |
Lakota, J | 1 |
Jonathan, F | 1 |
Fagnoni, P | 1 |
Milpied, N | 2 |
Limat, S | 1 |
Deconinck, E | 2 |
Nerich, V | 1 |
Foussard, C | 1 |
Harousseau, JL | 1 |
Woronoff-Lemsi, MC | 1 |
Koo, YX | 1 |
Tan, DS | 1 |
Tan, BH | 1 |
Quek, R | 1 |
Tao, M | 1 |
Lim, ST | 1 |
Kabiri, el H | 1 |
Kabiri, M | 1 |
Doghmi, K | 1 |
Sharma, R | 1 |
Cunningham, D | 6 |
Smith, P | 5 |
Robertson, G | 1 |
Dent, O | 1 |
Clarke, SJ | 1 |
Nishigori, K | 1 |
Yamamoto, T | 2 |
Yokozeki, H | 1 |
Hainsworth, JD | 2 |
Spigel, DR | 1 |
Markus, TM | 1 |
Shipley, D | 1 |
Thompson, D | 1 |
Rotman, R | 1 |
Dannaher, C | 1 |
Greco, FA | 2 |
Chaiwun, B | 1 |
Sukhamwang, N | 1 |
Ya-In, C | 1 |
Shuangshoti, S | 1 |
Kondo, M | 2 |
Kitada, N | 1 |
Kobayashi, M | 1 |
Morita, S | 1 |
Yoshioka, M | 1 |
Tsuji, T | 1 |
Mori, A | 2 |
Okamoto, T | 3 |
Watari, M | 1 |
Fridrik, MA | 3 |
Hausmaninger, H | 2 |
Lang, A | 1 |
Drach, J | 2 |
Krieger, O | 1 |
Geissler, D | 1 |
Michlmayr, G | 1 |
Ulsperger, E | 1 |
Chott, A | 3 |
Oberaigner, W | 1 |
Greil, R | 1 |
Dincol, D | 1 |
Buyukcelik, A | 1 |
Dogan, M | 1 |
Akbulut, H | 1 |
Samur, M | 1 |
Demirkazik, A | 1 |
Senler, FC | 1 |
Onur, H | 1 |
Icli, F | 1 |
Horikoshi, A | 1 |
Takei, K | 2 |
Iriyama, N | 1 |
Uenogawa, K | 1 |
Ishizuka, H | 1 |
Shiraiwa, H | 1 |
Hosokawa, Y | 1 |
Sawada, S | 1 |
Kitoh, T | 1 |
Katsuya, H | 1 |
Suzumiya, J | 3 |
Sasaki, H | 1 |
Ishitsuka, K | 1 |
Shibata, T | 1 |
Takamatsu, Y | 1 |
Tamura, K | 3 |
Lan, MX | 1 |
Zhen, ZX | 1 |
Ming, WH | 1 |
De, D | 1 |
Dogra, S | 1 |
Kanwar, AJ | 1 |
Saikia, UN | 1 |
Qiao, W | 1 |
Zhao, J | 1 |
Wang, C | 1 |
Wang, T | 1 |
Xing, Y | 1 |
Hoffmann, M | 2 |
Schirmer, MA | 1 |
Tzvetkov, MV | 1 |
Kreuz, M | 1 |
Ziepert, M | 2 |
Wojnowski, L | 1 |
Kube, D | 1 |
Pfreundschuh, M | 8 |
Trümper, L | 6 |
Loeffler, M | 8 |
Brockmöller, J | 1 |
Cunningham, S | 1 |
Muneer, S | 1 |
Ranganathan, A | 1 |
Shrader, M | 1 |
Laatiri, MA | 1 |
Elloumi, M | 1 |
Ali, ZB | 1 |
Ben Othmen, T | 1 |
Msadek, F | 1 |
Toumi, N | 1 |
Bouaouina, N | 1 |
Daoud, J | 1 |
Maalej, M | 1 |
Ghannem, H | 1 |
Meddeb, B | 1 |
Kiewe, P | 1 |
Thiel, E | 3 |
Demirkaya, M | 1 |
Sevinir, B | 1 |
Ozdemir, O | 1 |
Nazlioğlu, HO | 1 |
Okan, M | 1 |
De Moerloose, B | 1 |
Suciu, S | 1 |
Bertrand, Y | 1 |
Mazingue, F | 1 |
Robert, A | 1 |
Uyttebroeck, A | 1 |
Yakouben, K | 1 |
Ferster, A | 1 |
Margueritte, G | 1 |
Lutz, P | 1 |
Munzer, M | 1 |
Sirvent, N | 1 |
Norton, L | 2 |
Boutard, P | 1 |
Plantaz, D | 1 |
Millot, F | 1 |
Philippet, P | 1 |
Baila, L | 2 |
Benoit, Y | 1 |
Otten, J | 1 |
Cronin, PA | 1 |
Myers, E | 1 |
Redmond, HP | 1 |
O'Reilly, S | 1 |
Kirwan, WO | 1 |
Shamsian, BS | 1 |
Goudarzipour, K | 1 |
Alavi, S | 1 |
Jadali, F | 1 |
Gharib, A | 1 |
Aghakhani, R | 1 |
Arzanian, MT | 1 |
Rezaei, N | 1 |
Lee, SM | 1 |
Cheng, B | 1 |
Cheung, YK | 1 |
Aurer, I | 1 |
Eghbali, H | 1 |
Raemaekers, J | 1 |
Khaled, HM | 1 |
Fortpied, C | 1 |
van der Maazen, RW | 1 |
Haioun, C | 6 |
Salar, A | 1 |
Pettengell, R | 3 |
Johnsen, HE | 1 |
Duehrsen, U | 2 |
Rossi, FG | 2 |
Verhoef, G | 3 |
Schwenkglenks, M | 2 |
Jaeger, U | 1 |
Hamilton, L | 1 |
Pujol, B | 2 |
Lugtenburg, PJ | 2 |
Hirai, Y | 1 |
Ainoda, Y | 1 |
Shoji, T | 1 |
Fujita, T | 1 |
Yoshinaga, K | 1 |
Shiseki, M | 1 |
Mori, N | 1 |
Teramura, M | 1 |
Totsuka, K | 1 |
Motoji, T | 1 |
Schmitz, N | 6 |
Zeynalova, S | 3 |
Glass, B | 2 |
Kaiser, U | 5 |
Cavallin-Stahl, E | 2 |
Wolf, M | 1 |
Haenel, M | 2 |
Truemper, L | 2 |
Fløisand, Y | 1 |
Brinch, L | 1 |
Gedde-Dahl, T | 1 |
Tjønnfjord, GE | 1 |
Dybedal, I | 1 |
Holte, H | 1 |
Heldal, D | 1 |
Torfoss, D | 1 |
Aurlien, E | 1 |
Lauritzsen, GF | 1 |
Fosså, A | 1 |
Lehne, G | 1 |
Baggerød, E | 1 |
Kvalheim, G | 1 |
Egeland, T | 1 |
Bishop, MR | 1 |
Fowler, DH | 1 |
Kolstad, A | 1 |
Mizuno, R | 1 |
Fujimoto, S | 1 |
Okamoto, Y | 1 |
Silvestre, AS | 1 |
Wheeler, T | 1 |
Zyrina, GV | 1 |
Vose, JM | 2 |
Weisenburger, DD | 1 |
Lynch, JC | 1 |
Bierman, PJ | 1 |
Chan, JC | 1 |
Bast, M | 1 |
Aoun, P | 1 |
Bociek, G | 1 |
Greiner, T | 1 |
Armitage, JO | 3 |
Rummel, MJ | 1 |
Mitrou, PS | 1 |
Hoelzer, D | 1 |
Portlock, CS | 1 |
Balzarotti, M | 2 |
Spina, M | 1 |
Sarina, B | 1 |
Magagnoli, M | 1 |
Castagna, L | 1 |
Milan, I | 1 |
Ripa, C | 1 |
Latteri, F | 2 |
Bernardi, D | 1 |
Bertuzzi, A | 1 |
Nozza, A | 1 |
Roncalli, M | 1 |
Morenghi, E | 1 |
Tirelli, U | 2 |
Santoro, A | 2 |
Ohtsu, T | 2 |
Fukuda, H | 2 |
Sasaki, Y | 1 |
Ogura, M | 4 |
Morishima, Y | 3 |
Chou, T | 1 |
Aikawa, K | 1 |
Uike, N | 1 |
Mizorogi, F | 1 |
Ohno, T | 1 |
Ikeda, S | 2 |
Sai, T | 2 |
Taniwaki, M | 2 |
Kawano, F | 2 |
Niimi, M | 1 |
Hotta, T | 5 |
Shimoyama, M | 4 |
Tobinai, K | 4 |
Spaepen, K | 1 |
Stroobants, S | 1 |
Dupont, P | 1 |
Vandenberghe, P | 1 |
Thomas, J | 1 |
de Groot, T | 1 |
Balzarini, J | 1 |
De Wolf-Peeters, C | 1 |
Mortelmans, L | 1 |
van Agthoven, M | 1 |
Faber, LM | 1 |
Uyl-de Groot, CA | 1 |
Sonneveld, P | 5 |
Verdonck, LF | 3 |
Willemze, R | 1 |
Kluin-Nelemans, JC | 1 |
Löwenberg, B | 2 |
Huijgens, PC | 2 |
Fisher, RI | 3 |
Uebelacker, I | 1 |
Abel, U | 1 |
Birkmann, J | 2 |
Schmalenberg, H | 2 |
Karakas, T | 1 |
Metzner, B | 2 |
Hossfeld, DK | 1 |
Bischoff, HG | 1 |
Franke, A | 2 |
Reiser, M | 2 |
Müller, P | 1 |
Mantovani, L | 1 |
Grundeis, M | 1 |
Rothmann, F | 1 |
von Seydewitz, CU | 1 |
Mesters, RM | 1 |
Steinhauer, EU | 2 |
Krahl, D | 1 |
Schumacher, K | 1 |
Kneba, M | 1 |
Baudis, M | 2 |
Pfab, R | 5 |
Köppler, H | 4 |
Parwaresch, R | 1 |
Havemann, K | 3 |
Franco, A | 1 |
Jiménez, L | 1 |
Aranda, I | 1 |
Alvarez, L | 1 |
González, M | 1 |
Rocamora, N | 1 |
Olivares, J | 1 |
Stewart, AJ | 1 |
Southcott, BM | 1 |
Coiffier, B | 9 |
Mottl, H | 1 |
Bajciova, V | 1 |
Nemec, J | 1 |
Al Shemmari, S | 1 |
Al Awadi, S | 1 |
Shimizu, J | 1 |
Ishida, Y | 1 |
Takehara, A | 1 |
Kinoshita, T | 4 |
Tatsuzawa, Y | 1 |
Kawaura, Y | 1 |
Matsumoto, I | 1 |
Imai, M | 1 |
Bessell, EM | 3 |
Burton, A | 1 |
Haynes, AP | 1 |
Glaholm, J | 1 |
Child, JA | 2 |
Cullen, MH | 2 |
Davies, JM | 2 |
Smith, GM | 1 |
Ellis, IO | 2 |
Jack, A | 3 |
Jones, EL | 1 |
Herold, M | 2 |
Dölken, G | 1 |
Fiedler, F | 1 |
Freund, M | 1 |
Helbig, W | 1 |
Pasold, R | 1 |
Economopoulos, T | 3 |
Fountzilas, G | 3 |
Pavlidis, N | 3 |
Kalantzis, D | 1 |
Papageorgiou, E | 1 |
Christodoulou, C | 1 |
Hamilos, G | 1 |
Nicolaides, C | 2 |
Dimopoulos, M | 1 |
Pangalis, GA | 1 |
Vassilakopoulos, TP | 1 |
Michalis, E | 1 |
Roussou, P | 1 |
Vrakidou, E | 1 |
Repousis, P | 1 |
Angelopoulou, MK | 1 |
Siakantaris, MP | 1 |
Korantzis, J | 1 |
Symeonidis, A | 1 |
Grigorakis, V | 1 |
Stefanoudakis, E | 1 |
Stamatellou, M | 1 |
Bourantas, KL | 1 |
Kalmantis, T | 1 |
Christopoulos, G | 1 |
Kokkinis, G | 1 |
Mihalakeas, I | 1 |
Papayiannis, A | 1 |
Pileckyte, M | 1 |
Griniūte, R | 1 |
Wunderlich, A | 1 |
Kloess, M | 3 |
Rudolph, C | 1 |
Bittner, S | 1 |
Schmits, R | 2 |
Daum, S | 1 |
Ullrich, R | 1 |
Heise, W | 1 |
Dederke, B | 1 |
Foss, HD | 1 |
Stein, H | 1 |
Zeitz, M | 1 |
Riecken, EO | 1 |
Lee, JJ | 1 |
Nam, CE | 1 |
Cho, SH | 1 |
Park, KS | 1 |
Chung, IJ | 1 |
Kim, HJ | 2 |
Zhang, DS | 1 |
Jiang, WQ | 2 |
Li, S | 1 |
Zhang, XS | 1 |
Mao, H | 1 |
Chen, XQ | 1 |
Li, YH | 1 |
Zhan, J | 1 |
Wang, FH | 1 |
López-Duarte, M | 1 |
Insunza, A | 1 |
Conde, E | 1 |
Iriondo, A | 1 |
Mazorra, F | 1 |
Zubizarreta, A | 1 |
Mead, G | 1 |
Woodcock, J | 1 |
Young, C | 1 |
STACHER, A | 1 |
BOEHNEL, J | 1 |
KYLE, RA | 1 |
McPARLAND, CE | 1 |
DAMESHEK, W | 1 |
BENEDETTI, A | 1 |
FUSARO, A | 1 |
POLI, D | 1 |
GRODEN, BM | 1 |
DUNNIGAN, MG | 1 |
ARAPAKIS, G | 1 |
JORDANOGLOU, J | 1 |
AOKI, Y | 1 |
KAWABE, A | 1 |
MASHIMA, T | 1 |
OGURO, C | 1 |
ARDOUIN, AP | 1 |
LIBERTI, R | 1 |
PLATTNER, I | 1 |
SCHREK, R | 1 |
MURRAY, PJ | 1 |
SLADDEN, RA | 1 |
Lyman, GH | 3 |
Delgado, DJ | 3 |
Mandigers, CM | 1 |
Meijerink, JP | 1 |
Dekker, AW | 1 |
Schattenberg, AV | 1 |
Raemaekers, JM | 1 |
Tsurumi, H | 2 |
Yamada, T | 2 |
Sawada, M | 2 |
Kasahara, S | 2 |
Kanemura, N | 2 |
Kojima, Y | 2 |
Fukuno, K | 1 |
Hara, T | 2 |
Saio, M | 1 |
Takahashi, T | 2 |
Oyama, M | 2 |
Ozawa, K | 1 |
Takami, T | 1 |
Moriwaki, H | 2 |
Mantzios, G | 1 |
Tsirigotis, P | 1 |
Veliou, F | 1 |
Boutsikakis, I | 1 |
Petraki, L | 1 |
Kolovos, J | 1 |
Papageorgiou, S | 1 |
Robos, Y | 1 |
Morrison, VA | 3 |
Dale, DC | 2 |
Crawford, J | 2 |
Fridman, M | 2 |
Froehner, M | 1 |
Haase, M | 1 |
Hakenberg, OW | 1 |
Wirth, MP | 1 |
Sayarlioglu, M | 1 |
Bayram, I | 1 |
Sayarlioglu, H | 1 |
Erkoc, R | 1 |
Yamamura, R | 1 |
Yamane, T | 3 |
Aoyama, Y | 1 |
Nakamae, H | 1 |
Hasegawa, T | 1 |
Ohta, K | 1 |
Nakao, Y | 1 |
Ohta, T | 1 |
Mugitani, A | 1 |
Hino, M | 1 |
DiBiase, SJ | 1 |
Grigsby, PW | 1 |
Guo, C | 1 |
Lin, HS | 1 |
Wasserman, TH | 1 |
Gergely, L | 1 |
Aleksza, M | 1 |
Váróczy, L | 1 |
Ponyi, A | 1 |
Sipka, S | 1 |
Illés, A | 1 |
Szegedi, G | 1 |
Jung, CK | 1 |
Park, JS | 1 |
Lee, EJ | 1 |
Kim, SH | 1 |
Kwon, HC | 1 |
Kim, JS | 1 |
Roh, MS | 1 |
Yoon, SK | 1 |
Kim, KH | 1 |
Han, JY | 1 |
Tomandl, J | 1 |
Palyza, V | 1 |
Tallová, J | 1 |
Drbal, J | 1 |
Miller, TP | 1 |
Horning, SJ | 1 |
Weller, E | 1 |
Kim, K | 1 |
Earle, JD | 2 |
O'Connell, MJ | 1 |
Habermann, TM | 1 |
Glick, JH | 1 |
Jullien, V | 1 |
Perrin, C | 1 |
Peyrade, F | 1 |
Lemoigne, F | 1 |
Chichmanian, RM | 1 |
Blaive, B | 1 |
Osby, E | 2 |
Askling, J | 1 |
Landgren, O | 1 |
Dickman, PW | 1 |
Ekbom, A | 1 |
Björkholm, M | 3 |
Mounier, N | 2 |
Gisselbrecht, C | 7 |
Brière, J | 2 |
Feugier, P | 1 |
Offner, F | 1 |
Recher, C | 1 |
Stamatoullas, A | 1 |
Morschhauser, F | 2 |
Macro, M | 1 |
Thieblemont, C | 1 |
Sonet, A | 1 |
Fabiani, B | 1 |
Reyes, F | 4 |
Sinha, A | 1 |
Velangi, S | 1 |
Natarajan, S | 1 |
Coutinho, F | 2 |
Manhani, AR | 2 |
Velasquez, WS | 1 |
Del Giglio, A | 2 |
Friedberg, J | 1 |
Hidaka, S | 1 |
Takechi, S | 1 |
Nonaka, S | 1 |
Joko, K | 1 |
Vigliotti, ML | 1 |
Dell'Olio, M | 1 |
La Sala, A | 1 |
Romano, G | 1 |
Tartarone, A | 1 |
Mele, G | 1 |
Musto, C | 1 |
Carella, AM | 1 |
Di Renzo, N | 1 |
Grigg, A | 3 |
Czuczman, MS | 3 |
Weaver, R | 1 |
Alkuzweny, B | 1 |
Berlfein, J | 1 |
Grillo-López, AJ | 1 |
Constantinou, J | 1 |
Nitkunan, T | 1 |
Al-Izzi, M | 1 |
McNicholas, TA | 1 |
Alexandrescu, DT | 1 |
Dutcher, JP | 1 |
O'Boyle, K | 1 |
Albulak, M | 1 |
Oiseth, S | 1 |
Wiernik, PH | 1 |
Rossum, MM | 1 |
Verhaegen, NT | 1 |
Jonkman, MF | 1 |
Mackenzie, MA | 1 |
Koster, A | 1 |
Van Der Valk, PG | 1 |
Span, LF | 1 |
Kobayashi, T | 3 |
Ishizuka, N | 1 |
Tomonaga, M | 1 |
Ohno, Y | 2 |
Kasai, M | 1 |
Mikuni, C | 3 |
Toki, H | 2 |
Sano, M | 3 |
Masaki, Y | 1 |
Matsuno, Y | 2 |
Takenaka, T | 2 |
Shirakawa, S | 2 |
Othieno-Abinya, NA | 1 |
Abwao, HO | 1 |
Maina, JM | 1 |
Nyabola, LO | 1 |
Opiyo, A | 1 |
Njuguna, E | 1 |
Ndege, P | 1 |
Musibi, A | 1 |
Hatta, T | 1 |
Ohnishi, N | 1 |
Kusaba, T | 1 |
Tanda, S | 1 |
Narumiya, H | 1 |
Tamagaki, K | 1 |
Kameyama, H | 1 |
Yamada, K | 1 |
Sasaki, S | 3 |
Takeda, K | 1 |
Wöhrer, S | 1 |
Raderer, M | 1 |
Kaufmann, H | 1 |
Hejna, M | 1 |
Zielinski, CC | 1 |
Gershanovich, ML | 1 |
Tikhonova, VV | 1 |
Mori, M | 1 |
Kitamura, K | 2 |
Masuda, M | 1 |
Miyazaki, T | 1 |
Miura, AB | 3 |
Mizoguchi, H | 2 |
Shibata, A | 1 |
Saito, H | 2 |
Matsuda, T | 6 |
Masaoka, T | 5 |
Harada, M | 1 |
Niho, Y | 1 |
Takaku, F | 3 |
Fulignati, C | 1 |
Pantaleo, P | 1 |
Cipriani, G | 1 |
Turrini, M | 1 |
Nicastro, R | 1 |
Mazzanti, R | 1 |
Neri, B | 1 |
Bernard, M | 1 |
Cartron, G | 1 |
Rachieru, P | 1 |
LeMevel, A | 1 |
Branger, B | 1 |
Le Maignan, C | 1 |
Berthou, C | 1 |
Ghandour, C | 1 |
Cassasus, P | 1 |
Celigny, PS | 1 |
Guyotat, D | 1 |
Lamy, T | 1 |
Desablens, B | 1 |
Jabbour, E | 1 |
Peslin, N | 1 |
Arnaud, P | 1 |
Ferme, C | 2 |
Carde, P | 1 |
Vantelon, JM | 1 |
Bocaccio, C | 1 |
Bourhis, JH | 2 |
Koscielny, S | 1 |
Ribrag, V | 2 |
Hsiao, HH | 1 |
Sashida, G | 1 |
Ito, Y | 2 |
Tachino, M | 1 |
Beppu, H | 1 |
Ohyashiki, K | 1 |
Burton, C | 2 |
Vaughan-Hudson, G | 1 |
Qian, W | 2 |
Hoskin, P | 3 |
Hancock, B | 3 |
Linch, D | 3 |
Macartney, C | 1 |
Burke, E | 1 |
Elborn, S | 1 |
Magee, N | 1 |
Noone, P | 1 |
Gleadhill, I | 1 |
Allen, D | 1 |
Kettle, P | 1 |
Drake, M | 1 |
Kambayashi, T | 1 |
Ono, N | 1 |
Terada, Y | 1 |
Taga, T | 2 |
Sakaue, Y | 1 |
Anzai, Y | 1 |
Takeuchi, Y | 1 |
Ohta, S | 1 |
Mizoroki, F | 1 |
Hirose, Y | 1 |
Nakata, M | 1 |
Uozumi, K | 1 |
Sawada, K | 2 |
Fukuhara, S | 2 |
Nasu, K | 2 |
Togawa, A | 1 |
Kikuchi, M | 5 |
Motomura, S | 5 |
Hashimoto, C | 1 |
Kodama, F | 5 |
Maruta, A | 4 |
Sakai, R | 3 |
Fujita, H | 3 |
Tomita, N | 3 |
Fujisawa, S | 3 |
Harano, H | 3 |
Koharazawa, H | 1 |
Fujimaki, K | 1 |
Kanamori, H | 5 |
Ishigatsubo, Y | 2 |
Darling, MR | 1 |
Daley, T | 1 |
Milligan, D | 2 |
Dyer, MJ | 1 |
Mouncey, P | 1 |
MacLennan, K | 2 |
Webb, A | 1 |
Yoshikawa, T | 1 |
Goto, N | 1 |
Tomita, E | 1 |
Kagami, Y | 2 |
Watanabe, T | 1 |
Igarashi, T | 2 |
Ohashi, Y | 1 |
Mori, S | 1 |
Terauchi, T | 1 |
Herishanu, Y | 1 |
Polliack, A | 1 |
Leider-Trejo, L | 1 |
Grieff, Y | 1 |
Metser, U | 1 |
Naparstek, E | 1 |
Adenipekun, A | 1 |
Abudus-Salam, A | 1 |
Elumele, TN | 1 |
Shikama, N | 2 |
Oguchi, M | 2 |
Isobe, K | 1 |
Nakamura, K | 3 |
Tamaki, Y | 1 |
Hasegawa, M | 1 |
Kodaira, T | 1 |
Niitsu, N | 3 |
Okamoto, M | 3 |
Kohori, M | 1 |
Aoki, S | 1 |
Miura, I | 1 |
Hirano, M | 4 |
Vassallo, E | 1 |
Di Noto, L | 1 |
Palmeri, L | 1 |
Vaglica, M | 1 |
Pancera, G | 1 |
Palmeri, S | 1 |
Boehme, V | 1 |
Sawicka-Zukowska, M | 1 |
Kajdas, L | 1 |
Muszynska-Roslan, K | 1 |
Krawczuk-Rybak, M | 1 |
Sonta-Jakimczyk, D | 1 |
Szczepanski, T | 1 |
Tanaka, PY | 1 |
Pracchia, LF | 1 |
Calore, EE | 1 |
Dantas, AA | 1 |
Sugimoto, T | 3 |
Matano, S | 4 |
Nishijima, H | 1 |
Kakuta, K | 1 |
Inamura, K | 1 |
Okamura, T | 1 |
Munemoto, S | 1 |
Satoh, S | 1 |
Maciel, JF | 1 |
de Lourdes Chauffaille, M | 1 |
Inaoka, RJ | 1 |
Colleoni, GW | 2 |
Yamamoto, M | 1 |
Rund, D | 1 |
Burgess, M | 1 |
Sloots, L | 1 |
Bouafia, F | 1 |
Dumontet, C | 3 |
Khalid, S | 1 |
Adil, SN | 1 |
Vaziri, IA | 1 |
Kroschinsky, FP | 1 |
Friedrichsen, K | 1 |
Mueller, J | 1 |
Pursche, S | 1 |
Prondzinsky, R | 1 |
Ehninger, G | 1 |
Schleyer, E | 1 |
Busse, A | 1 |
Hütter, G | 1 |
Siehl, JM | 1 |
Schmittel, A | 1 |
Keilholz, U | 1 |
Li, ZM | 1 |
Zhu, ZY | 1 |
Zhu, XF | 1 |
Zhou, JM | 1 |
Liu, ZC | 1 |
Yang, DJ | 1 |
Guang, ZZ | 1 |
Widmann, T | 1 |
Kneer, H | 1 |
König, J | 1 |
Herrmann, M | 1 |
Ohye, H | 1 |
Fukata, S | 1 |
Hirokawa, M | 1 |
Navarro, JT | 1 |
Ribera, JM | 1 |
Oriol, A | 1 |
Xicoy, B | 1 |
Mate, JL | 1 |
Sirera, G | 1 |
Lloveras, N | 1 |
Millá, F | 1 |
Feliu, E | 1 |
Zwick, C | 2 |
Dührsen, U | 1 |
Pflüger, KH | 4 |
Vrieling, T | 1 |
Mesters, R | 1 |
Mergenthaler, HG | 1 |
Einsele, H | 1 |
Bentz, M | 3 |
Lengfelder, E | 1 |
Rübe, C | 2 |
Cheng, MH | 1 |
Chao, HT | 1 |
Wang, PH | 1 |
Lim, KH | 1 |
Chiou, TY | 1 |
Lin, CJ | 1 |
Hsieh, RK | 2 |
Hohloch, K | 1 |
Mohren, M | 1 |
Liersch, R | 1 |
Graeven, U | 1 |
Wruck, U | 1 |
Hasenclever, D | 1 |
Basecke, J | 1 |
Podleschny, M | 1 |
Becker, A | 1 |
Seiffert, E | 1 |
Schwiers, I | 1 |
Schwiers, R | 1 |
Haase, D | 1 |
Griesinger, F | 1 |
Magnus, B | 1 |
Andersson, T | 1 |
Tomas, A | 1 |
Ahlbom, A | 1 |
Anders, A | 1 |
Eva, O | 1 |
Mitchell, PL | 1 |
Marlton, P | 1 |
Seymour, JF | 1 |
Hertzberg, M | 1 |
Enno, A | 1 |
Herrmann, R | 1 |
Bond, R | 1 |
Arthur, C | 1 |
Hohenwallner, W | 1 |
Höche, D | 1 |
Wutke, K | 1 |
Rüdiger, KD | 1 |
Anger, G | 1 |
Kästner, R | 1 |
Borisov, VI | 1 |
Korobkova, LI | 1 |
Vashakmadze, LA | 1 |
Frank, GA | 1 |
Abdyldaev, RA | 1 |
Kruglova, GV | 7 |
Ideström, K | 1 |
Kimby, E | 2 |
Mellstedt, H | 1 |
Engstedt, L | 1 |
Gahrton, G | 1 |
Johansson, B | 1 |
Killander, D | 1 |
Robérts, KH | 1 |
Stalfelt, AM | 1 |
Udén, AM | 1 |
Wadman, B | 1 |
Wählby, S | 2 |
Kondrat'eva, NA | 2 |
Lorie, IuI | 3 |
Vorob'ev, AI | 1 |
Brilliant, MD | 1 |
Blackledge, G | 1 |
Bush, H | 1 |
Chang, J | 1 |
Crowther, D | 3 |
Deakin, DP | 2 |
Dodge, OG | 1 |
Garrett, JV | 1 |
Palmer, M | 1 |
Pearson, D | 1 |
Scarffe, JH | 3 |
Todd, ID | 1 |
Wilkinson, PM | 2 |
Makhonova, LA | 1 |
Maiakova, SA | 1 |
Vialushkin, BIa | 1 |
McAdam, B | 1 |
Smith, T | 1 |
Love, WC | 1 |
Murphy, M | 1 |
Daly, PA | 1 |
Inoue, T | 2 |
Fujiyama, Y | 1 |
Kitoh, K | 1 |
Niwakawa, M | 1 |
Andoh, A | 1 |
Hodohara, K | 1 |
Bamba, T | 1 |
Hosoda, S | 1 |
Cooper, IA | 2 |
Wolf, MM | 1 |
Robertson, TI | 1 |
Fox, RM | 1 |
Matthews, JP | 2 |
Stone, JM | 1 |
Ding, JC | 2 |
Dart, G | 1 |
Matthews, J | 1 |
Firkin, FC | 1 |
Delmer, A | 1 |
Bauduer, F | 1 |
Ruskoné-Fourmestraux, A | 1 |
Ajchenbaum-Cymbalista, F | 1 |
Delmas-Marsalet, B | 1 |
Rio, B | 1 |
Marie, JP | 1 |
Zittoun, R | 1 |
Morel, P | 4 |
Dupriez, B | 2 |
Herbrecht, R | 7 |
Bastion, Y | 2 |
Tilly, H | 6 |
Delannoy, A | 1 |
Nouvel, C | 2 |
Bouabdallah, K | 1 |
Baumelou, E | 1 |
Tanabe, J | 4 |
Matsuzaki, M | 3 |
Mohri, H | 1 |
Okubo, T | 2 |
Lishner, M | 1 |
Slingerland, J | 1 |
Theresa, C | 1 |
Sutcliffe, SB | 1 |
Jackson, GH | 1 |
Lennard, AL | 2 |
Taylor, PR | 2 |
Carey, P | 1 |
Angus, B | 2 |
Lucraft, H | 1 |
Evans, RG | 2 |
Proctor, SJ | 2 |
Tanosaki, R | 1 |
Okamoto, S | 1 |
Akatsuka, N | 1 |
Ishida, A | 1 |
Michikawa, N | 1 |
Masuda, Y | 1 |
Uchida, H | 1 |
Murata, M | 1 |
Kizaki, M | 1 |
Ikeda, Y | 1 |
Lepage, E | 3 |
Bosly, A | 4 |
D'Agay, MF | 1 |
Norum, J | 1 |
Aasebø, U | 1 |
O'Neill, BP | 1 |
O'Fallon, JR | 1 |
Colgan, JP | 1 |
Brown, LD | 1 |
Krigel, RL | 1 |
Brada, M | 1 |
Dreger, P | 1 |
Klöss, M | 2 |
Petersen, B | 1 |
Haferlach, T | 1 |
Löffler, H | 1 |
de Ridder, M | 1 |
van der Lelie, H | 1 |
Nieuwenhuis, K | 2 |
Schouten, H | 1 |
Mulder, A | 1 |
van Reijswoud, I | 1 |
Hop, W | 2 |
Cabanillas, FC | 1 |
Velasquez, W | 2 |
Hagemeister, FB | 1 |
Swan, F | 2 |
Romaguera, JE | 1 |
Sharma, UK | 1 |
Jha, V | 1 |
Joshi, K | 1 |
Ahmed, S | 1 |
Sakhuja, V | 1 |
Bezwoda, W | 1 |
Rastogi, RB | 1 |
Erazo Valla, A | 1 |
Diaz-Maqueo, JC | 1 |
Pavlovsky, S | 2 |
Morioka, H | 1 |
Resegotti, L | 1 |
Rueckle, H | 1 |
Somoza, N | 2 |
Moreno-Nogueira, JA | 1 |
Taillan, B | 1 |
Garnier, G | 1 |
Schneider, S | 1 |
Pesce, A | 1 |
Fuzibet, JG | 2 |
Dujardin, P | 1 |
Cuthbert, RJ | 1 |
Craig, JI | 1 |
Ludlam, CA | 1 |
Ang, PT | 2 |
Soh, LT | 2 |
Sng, I | 2 |
Chua, EJ | 2 |
Ong, YW | 2 |
Schofield, K | 1 |
Morris, D | 1 |
Klapper, P | 1 |
Waits, TM | 1 |
Greer, JP | 1 |
Kohda, K | 1 |
Tsuji, A | 1 |
Takayanagi, N | 1 |
Takeda, M | 1 |
Hayashi, S | 1 |
Takimoto, R | 1 |
Fujisaki, Y | 1 |
Tsuji, Y | 1 |
Ezoe, A | 1 |
Nakazawa, O | 1 |
Sebban, C | 3 |
Takeshima, M | 1 |
Nakamura, S | 7 |
Mochizuki, Y | 1 |
Hattori, N | 1 |
Kaya, H | 1 |
Otake, S | 1 |
Okabe, Y | 1 |
Okumura, H | 1 |
Yoshida, T | 5 |
Evans, TR | 1 |
Mansi, JL | 1 |
Bevan, DH | 1 |
Dalgleish, AG | 1 |
Harmer, CL | 1 |
Shimizu, H | 1 |
Takaue, Y | 1 |
Utsumi, J | 1 |
Takeda, T | 1 |
Fujimoto, T | 3 |
Reiter, A | 2 |
Bernard, T | 1 |
Johnson, SA | 1 |
Prentice, AG | 2 |
Jones, L | 1 |
Phillips, MJ | 1 |
Newland, AC | 5 |
Pendleton, N | 1 |
Green, JA | 3 |
Cowley, NC | 1 |
Neill, SM | 1 |
Staughton, RC | 1 |
Obrist, R | 1 |
Coutts, A | 1 |
Fletcher, J | 2 |
Toghill, PJ | 1 |
Moloney, AJ | 1 |
Hulman, G | 1 |
Jenkins, D | 1 |
Chan-Lam, D | 1 |
Copplestone, JA | 1 |
Weston, M | 1 |
Williams, M | 1 |
Hutton, CW | 1 |
Nenning, H | 1 |
Meier, P | 1 |
Penk, A | 1 |
Kössling, S | 1 |
Mulder, AH | 1 |
Michiels, JJ | 2 |
Blijham, G | 1 |
van de Lelie, J | 1 |
Raemakers, JW | 1 |
van der Heul, C | 1 |
Eschenbach, I | 3 |
Zeller, W | 2 |
Holle, R | 1 |
Steinhauer, UE | 1 |
Gropp, C | 2 |
Oehl, S | 2 |
Bezwoda, WR | 1 |
Bezwoda, MA | 1 |
Seymour, L | 1 |
Dansey, R | 1 |
Ariad, S | 1 |
Sampi, K | 4 |
Takagi, T | 5 |
Morii, K | 1 |
Hattori, M | 4 |
Matsuura, Y | 1 |
Nakamura, H | 2 |
Kogure, K | 1 |
Fukazawa, M | 1 |
Okuyama, Y | 1 |
Kawano, E | 1 |
Ishii, A | 1 |
Nishimura, M | 1 |
Hashimoto, S | 1 |
Oh, H | 2 |
Doi, M | 1 |
Hisada, Y | 1 |
Namba, R | 1 |
Nakata, Y | 1 |
Saika, Y | 1 |
Shimizu, T | 1 |
Sueyoshi, K | 1 |
Kawai, T | 1 |
Narabayashi, I | 1 |
Hickish, T | 1 |
Roldan, A | 1 |
Mansi, J | 1 |
Ashley, S | 1 |
Nicolson, V | 1 |
Gore, ME | 1 |
Catovsky, D | 1 |
Smith, IE | 1 |
Okamoto, R | 1 |
Tamura, T | 1 |
Murata, T | 1 |
Hashimoto, Y | 1 |
Yokoi, M | 1 |
Nagai, T | 1 |
Hirabayashi, M | 1 |
Okamura, A | 1 |
Tatsumi, E | 1 |
Nishikori, M | 1 |
Garrett, TJ | 1 |
Chadburn, A | 1 |
Barr, ML | 1 |
Drusin, RE | 1 |
Chen, JM | 1 |
Schulman, LL | 1 |
Smith, CR | 1 |
Reison, DS | 1 |
Rose, EA | 1 |
Michler, RE | 1 |
Sweetenham, JW | 1 |
McKendrick, JJ | 1 |
Mead, GM | 1 |
Whitehouse, JM | 1 |
Toogood, IR | 1 |
Tiedemann, K | 1 |
Stevens, M | 1 |
Smith, PJ | 1 |
Chisesi, T | 2 |
Cajozzo, A | 1 |
Leone, G | 2 |
Papa, G | 2 |
Gentilini, P | 1 |
Aitini, E | 1 |
Mandelli, F | 2 |
Linkesch, W | 1 |
Stöger, M | 1 |
Sill, H | 1 |
Neubauer, M | 1 |
Seewann, HL | 1 |
Klocker, J | 1 |
Haidinger, R | 1 |
Schiller, L | 1 |
Pont, J | 1 |
Raudaschl, G | 1 |
Falk, M | 1 |
Radaszkiewicz, T | 1 |
Ferreri, AJ | 1 |
Reni, M | 1 |
Bolognesi, A | 1 |
Verusio, C | 1 |
Villa, E | 1 |
Silingardi, V | 1 |
Federico, M | 2 |
Cavanna, L | 2 |
Avanzini, P | 2 |
Gobbi, PG | 2 |
Lombardo, M | 2 |
Carotenuto, M | 2 |
Frassoldati, A | 1 |
Pieresca, C | 1 |
Vallisa, D | 1 |
Phillips, JK | 1 |
Sherlaw-Johnson, C | 1 |
Clough, JV | 1 |
Parry, H | 1 |
Nash, JR | 2 |
Cawley, JC | 1 |
Kobayashi, K | 5 |
Misaki, T | 1 |
Landys, KE | 2 |
Berg, GE | 1 |
Torgerson, JS | 1 |
Klingenstierna, HA | 1 |
Ridell, BS | 1 |
Johansson, BR | 1 |
Radford, JA | 1 |
Morgenstern, GR | 1 |
Harris, M | 2 |
Woll, PJ | 1 |
Ryder, D | 1 |
Linch, DC | 2 |
Vaughan Hudson, B | 1 |
Hancock, BW | 2 |
Hoskin, PJ | 3 |
Cunningham, DC | 2 |
Milligan, DW | 1 |
Stevenson, PA | 2 |
Wood, JK | 2 |
MacLennan, KA | 2 |
Anderson, L | 1 |
Gregory, WM | 2 |
Vaughan Hudson, G | 1 |
Sasai, K | 1 |
Yamabe, H | 2 |
Haga, H | 1 |
Tsutsui, K | 2 |
Dodo, Y | 2 |
Ishigaki, T | 1 |
Shibamoto, Y | 2 |
Abe, M | 3 |
Pettelot, G | 1 |
Gibelin, P | 1 |
Blanc, P | 1 |
Hoffman, P | 1 |
Ferrari, E | 1 |
Baudouy, M | 1 |
Morand, P | 1 |
Pääkkö, E | 1 |
Vainionpää, L | 1 |
Pyhtinen, J | 1 |
Lanning, M | 1 |
Brault, P | 1 |
Gilles, E | 1 |
Munck, JN | 2 |
Pico, JL | 1 |
Hayat, M | 1 |
Korobko, VB | 1 |
Chernyĭ, VA | 1 |
Valetskiĭ, VL | 1 |
Rozumiĭ, DA | 1 |
Gunina, LM | 1 |
Finogenova, IA | 2 |
Izumi, T | 1 |
Ohtsuki, T | 1 |
Ohya, K | 1 |
Ogawa, Y | 1 |
Yoshida, M | 4 |
Imagawa, S | 1 |
Hatake, K | 1 |
Kuriki, K | 1 |
Saito, K | 1 |
Miura, Y | 1 |
Maeda, N | 1 |
Nishizaki, S | 1 |
Furubayashi, T | 1 |
Sano, F | 2 |
Koike, M | 2 |
Ishibashi, M | 1 |
Tuji, K | 1 |
Katoh, M | 2 |
Hasegawa, S | 2 |
Maeba, T | 1 |
Takahashi, M | 2 |
Ohwada, S | 1 |
Ishida, M | 1 |
Burney, IA | 1 |
Malik, IA | 1 |
Taguchi, J | 2 |
Fukawa, H | 2 |
Mouri, H | 1 |
Gupta, NM | 1 |
Goenka, MK | 1 |
Jindal, A | 1 |
Behera, A | 1 |
Vaiphei, K | 1 |
Fahlenkamp, D | 1 |
Reinke, P | 1 |
Kirchner, S | 1 |
Schnorr, D | 1 |
Lindeke, A | 1 |
Loening, SA | 1 |
Grzelec, H | 1 |
Fryze, C | 1 |
Nowacki, P | 1 |
Zdziarska, B | 2 |
Laurencet, FM | 1 |
Zulian, GB | 1 |
Dietrich, PY | 2 |
Anchisi, S | 1 |
Mermillod, B | 1 |
Alberto, P | 1 |
Guerci, A | 1 |
Lederlin, P | 3 |
Bordessoule, D | 2 |
Kerneis, Y | 1 |
Biron, P | 1 |
Nakayama, M | 3 |
Umeda, M | 1 |
Newell, M | 1 |
Goldstein, D | 1 |
Milliken, S | 1 |
Lewis, C | 1 |
Hoy, J | 1 |
Thomson, B | 1 |
Cooper, D | 1 |
Izuno, I | 1 |
Gomi, K | 1 |
Sone, S | 1 |
Ramesh, V | 1 |
Tanwar, RK | 1 |
Kaushal, R | 1 |
Rath, GK | 1 |
Vaid, A | 1 |
Pathak, V | 1 |
Choubey, RP | 1 |
Kawasaki, G | 1 |
Nakai, M | 1 |
Mizuno, A | 1 |
Nakamura, T | 3 |
Okabe, H | 1 |
Kutluk, MT | 1 |
Hazar, V | 1 |
Akyüz, C | 1 |
Varan, A | 1 |
Büyükpamukçu, M | 1 |
Uehara, S | 1 |
Omagari, J | 1 |
Kunitake, N | 1 |
Jingu, K | 1 |
Masuda, K | 1 |
Kamieńska, E | 1 |
Luraschi, A | 1 |
Saglietti, G | 1 |
Ferrari, V | 1 |
Fedeli, P | 1 |
Ripamonti, G | 1 |
Gioria, A | 1 |
Bersi, M | 1 |
Ninomiya, H | 1 |
Kamoshita, M | 1 |
Ohtani, K | 1 |
Kojima, H | 2 |
Nagasawa, T | 1 |
Abe, T | 2 |
Hovgaard, DJ | 1 |
Stahl Skov, P | 1 |
Nissen, NI | 1 |
Blay, JY | 1 |
Divine, M | 1 |
Brice, P | 2 |
Blanc, M | 1 |
Salles, B | 1 |
Cameron, DA | 1 |
White, JM | 1 |
Prescott, RJ | 1 |
Leonard, RC | 1 |
Cook, MK | 1 |
Dawes, PJ | 1 |
Dawson, AA | 2 |
Galloway, MJ | 1 |
Harris, AL | 1 |
Heppleston, A | 1 |
Horne, CH | 1 |
Krajewski, AS | 1 |
Lessells, AM | 1 |
Lucraft, HH | 1 |
MacGillivray, JB | 1 |
Mackie, MJ | 1 |
Parker, AC | 1 |
Roberts, JT | 1 |
Thompson, WD | 1 |
Maruyama, K | 1 |
Sasako, M | 1 |
Sano, T | 1 |
Katai, H | 1 |
McNeil, C | 1 |
Geit, M | 1 |
Wahl, G | 1 |
Ehrengruber, A | 1 |
Simma, R | 1 |
Höpfel, I | 1 |
Bettelheim, P | 1 |
Leisch, F | 1 |
Chapman, R | 1 |
Szer, J | 1 |
Bos, GM | 1 |
van Putten, WL | 1 |
van der Holt, B | 1 |
van den Bent, M | 1 |
Hagenbeek, A | 1 |
Tsurusawa, M | 3 |
Yamamoto, Y | 2 |
Katano, N | 3 |
Hirota, T | 2 |
Miyawaki, T | 2 |
Yanase, T | 2 |
Koizumi, S | 3 |
Utumi, J | 1 |
Asami, K | 3 |
Tanaka, A | 2 |
Mugisima, H | 2 |
Hatae, Y | 2 |
Sekine, I | 2 |
Tsuchiya, T | 1 |
Yamamura, Y | 2 |
Iwai, A | 3 |
Kono, Y | 1 |
Simokawa, T | 1 |
Nisikawa, K | 1 |
Matusita, T | 1 |
Osima, K | 2 |
Yokota, S | 1 |
Eguchi, H | 1 |
Urasiński, I | 1 |
Wichert, K | 1 |
Zuk, E | 1 |
Gómez, H | 1 |
Colomer, R | 1 |
Hirokawa, N | 1 |
Hareyama, M | 1 |
Akiba, H | 1 |
Satoh, M | 1 |
Oouchi, A | 1 |
Tamakawa, M | 1 |
Sakata, K | 1 |
Nagakura, H | 1 |
Koito, K | 1 |
Harabuchi, Y | 1 |
Kataura, A | 1 |
Hinoda, Y | 1 |
Bailey, NP | 1 |
Stuart, NS | 1 |
Norfolk, D | 1 |
Grieve, RJ | 1 |
Simmons, AV | 1 |
Barnard, DL | 1 |
Farish, J | 1 |
Dunn, J | 1 |
Woodroffe, CM | 1 |
Stack, C | 1 |
Bloor, AJ | 1 |
Seale, JR | 1 |
Marcus, RE | 1 |
Atlan-Gepner, C | 1 |
Bouabdallah, R | 1 |
Valero, R | 1 |
Coso, D | 1 |
Vialettes, B | 1 |
Rafel, M | 1 |
Esteve, J | 1 |
Cervantes, F | 1 |
Velasco, M | 1 |
Serra, A | 1 |
Campo, E | 1 |
Montserrat, E | 1 |
Nishida, S | 1 |
Kuroko, K | 1 |
Hoshino, T | 1 |
Iwamoto, T | 2 |
Shirai, C | 1 |
Yalçin, S | 1 |
Kars, A | 1 |
Ozişik, Y | 1 |
Tekuzman, G | 1 |
Ozyilkan, O | 1 |
Celik, I | 1 |
Barişta, I | 1 |
Güllü, I | 1 |
Güler, N | 1 |
Baltali, E | 1 |
Firat, D | 1 |
Kersten, MJ | 1 |
Verduyn, TJ | 1 |
Reiss, P | 1 |
Evers, LM | 1 |
de Wolf, F | 1 |
van Oers, MH | 1 |
Ito, M | 1 |
Nishikawa, K | 1 |
Horikoshi, Y | 2 |
Anami, K | 2 |
Kaneko, Y | 1 |
Kataoka, S | 1 |
Chin, M | 1 |
Watanabe, A | 2 |
Van Leeuwen-Stok, EA | 1 |
Jonkhoff, AR | 1 |
Visser-Platier, AW | 1 |
Dräger, LM | 1 |
Teule, GJ | 1 |
Schuurhuis, GJ | 1 |
Plantier-Colcher, I | 1 |
Simon, M | 1 |
Detourmignies, L | 1 |
Jouet, JP | 1 |
Fenaux, P | 1 |
Bauters, F | 1 |
Takimoto, Y | 1 |
Eguchi, M | 1 |
Eguchi-Ishimae, M | 1 |
Imanaka, F | 1 |
Kamada, N | 1 |
Bremnes, RM | 1 |
Bremnes, Y | 1 |
Dønnem, T | 1 |
Xiros, N | 1 |
Samantas, E | 2 |
Raptis, S | 1 |
Dranitsaris, G | 1 |
Altmayer, C | 1 |
Quirt, I | 1 |
Farrell, AM | 1 |
Henry, K | 1 |
Woodrow, D | 1 |
Francis, N | 1 |
Newlands, ES | 2 |
Mitchell, DN | 1 |
Cream, JJ | 1 |
Macpherson, N | 1 |
Lesack, D | 1 |
Klasa, R | 1 |
Horsman, D | 1 |
Connors, JM | 1 |
Barnett, M | 1 |
Gascoyne, RD | 1 |
Tondini, C | 1 |
Zanini, M | 1 |
Giardini, R | 1 |
Rampinelli, I | 1 |
Bufalino, R | 1 |
Tarumi, T | 1 |
Koizumi, K | 1 |
Takano, H | 1 |
Fukada, Y | 1 |
Nishio, M | 1 |
Fujie, T | 1 |
Ohnishi, K | 1 |
Kohno, M | 1 |
Sato, N | 1 |
Sekiguchi, S | 1 |
Koike, T | 1 |
Tomlinson, J | 1 |
Tighe, M | 1 |
Johnson, S | 1 |
Stone, R | 1 |
Nicholson, AG | 1 |
Rule, S | 1 |
Fitoussi, O | 1 |
Simon, D | 2 |
Makke, J | 1 |
Scrobohaci, ML | 1 |
Bibi Triki, T | 1 |
Hennequin, C | 1 |
Schrappe, M | 1 |
Tiemann, M | 1 |
Ludwig, WD | 1 |
Yakisan, E | 1 |
Zimmermann, M | 1 |
Mann, G | 1 |
Ebell, W | 1 |
Klingebiel, T | 1 |
Graf, N | 1 |
Kremens, B | 1 |
Müller-Weihrich, S | 1 |
Plüss, HJ | 1 |
Zintl, F | 1 |
Henze, G | 1 |
Riehm, H | 1 |
Jerkeman, M | 1 |
Anderson, H | 1 |
Dictor, M | 1 |
Hagberg, H | 1 |
Johnson, A | 1 |
Kaasa, S | 1 |
Kvaløy, S | 1 |
Sundström, C | 1 |
Akerman, M | 2 |
Harries, SR | 1 |
Fox, BM | 1 |
Williams, MP | 1 |
McBride, NC | 2 |
Ward, MC | 2 |
Mills, MJ | 2 |
Eden, AG | 1 |
Hughes, A | 2 |
Cavenagh, JD | 2 |
Lamont, A | 1 |
Kelsey, SM | 2 |
Vaughan, B | 1 |
Vaughan, G | 1 |
Yamazaki, T | 1 |
Kura, Y | 1 |
Sawada, U | 1 |
Takemoto, Y | 2 |
Wada, H | 1 |
Takatsuka, H | 2 |
Kakishita, E | 3 |
Re, D | 1 |
Schwenk, A | 1 |
Hegener, P | 1 |
Bamborschke, S | 1 |
Diehl, V | 1 |
Tesch, H | 1 |
Mir, N | 1 |
Edmonson, R | 1 |
Yeghen, T | 1 |
Rashid, H | 1 |
Koharasawa, H | 1 |
Miyashita, H | 1 |
Ogawa, K | 1 |
Várkonyi, J | 1 |
Zalatnai, A | 1 |
Timár, J | 1 |
Matolcsi, A | 1 |
Falus, A | 1 |
Bencsáth, M | 1 |
László, V | 1 |
Pócsik, E | 1 |
Kotlán, B | 1 |
Császár, A | 1 |
Suzuki, K | 1 |
Sai, S | 1 |
Kato, K | 1 |
Murase, T | 1 |
Geetha, N | 1 |
Jayasree, K | 1 |
Ittiyavirah, AK | 1 |
Lali, VS | 1 |
Nair, MK | 1 |
Raspagliesi, F | 1 |
Ditto, A | 1 |
Fontanelli, R | 1 |
Gallino, G | 1 |
Massone, PB | 1 |
De Palo, G | 1 |
Kuraishi, Y | 2 |
Miyake, M | 1 |
Kikuta, A | 1 |
Kawano, Y | 1 |
Mugishima, H | 1 |
Matsushita, T | 1 |
Cavalot, AL | 1 |
Preti, G | 1 |
Vione, N | 1 |
Nazionale, G | 1 |
Palonta, F | 1 |
Fadda, GL | 1 |
Peters, FP | 1 |
Lalisang, RI | 1 |
Fickers, MM | 1 |
Erdkamp, FL | 1 |
Wils, JA | 1 |
Houben, SG | 1 |
Wals, J | 1 |
Schouten, HC | 1 |
Mainwaring, PN | 1 |
Gregory, W | 1 |
Norton, AJ | 1 |
Hudson, GV | 1 |
Kitajima, H | 1 |
Tsudo, M | 1 |
Fujimoto, M | 1 |
Hayashi, K | 4 |
Ohno, H | 1 |
Konaka, Y | 1 |
Katsurada, T | 1 |
Arima, N | 1 |
Doi, S | 1 |
Moriguchi, T | 1 |
Brandt, L | 2 |
Nygren, P | 1 |
Glimelius, B | 1 |
Baba, K | 1 |
Yajima, M | 1 |
Minagawa, N | 1 |
Kazama, A | 1 |
Grant, I | 1 |
Schey, S | 1 |
Gray, A | 1 |
Cervi, P | 1 |
Picozzi, VJ | 1 |
Pohlman, BL | 1 |
Lawless, GD | 1 |
Lee, MW | 1 |
Kerr, RO | 1 |
Ford, JM | 1 |
Carter, WB | 1 |
Akutsu, M | 1 |
Kano, Y | 2 |
Ogawa, M | 3 |
Miura, A | 1 |
Tatsumi, N | 1 |
Lanza, F | 1 |
Campioni, D | 1 |
Moretti, S | 1 |
Dominici, M | 1 |
Punturieri, M | 1 |
Focarile, E | 1 |
Pauli, S | 1 |
Dabusti, M | 1 |
Tieghi, A | 1 |
Bacilieri, M | 1 |
Scapoli, C | 1 |
De Angeli, C | 1 |
Galluccio, L | 1 |
Castoldi, G | 1 |
Schley, G | 1 |
Kauffold, D | 1 |
Guse, E | 1 |
Slucka, S | 1 |
Jeschke, M | 1 |
Wessendorf, S | 1 |
Lichter, P | 1 |
Schwänen, C | 1 |
Fritz, B | 1 |
Walenta, K | 1 |
Döhner, H | 1 |
Nguyen, TP | 1 |
Pfreunschuh, M | 1 |
Nishiyama, Y | 1 |
Fukunaga, K | 1 |
Satoh, K | 1 |
Ohkawa, M | 1 |
Yong, W | 1 |
Zheng, W | 1 |
Zhang, Y | 1 |
Basaran, M | 1 |
Bavbek, ES | 1 |
Sakar, B | 1 |
Eralp, Y | 1 |
Alici, S | 1 |
Tas, F | 1 |
Yaman, F | 1 |
Dogan O, O | 1 |
Camlica, H | 1 |
Onat, H | 1 |
Siemens, HJ | 1 |
Gerke, P | 1 |
Steinhoff, J | 1 |
Roth-Isigkeit, A | 1 |
Wagner, K | 1 |
Brückner, S | 1 |
Malik, R | 1 |
Gabor, LJ | 1 |
Foster, SF | 1 |
McCorkell, BE | 1 |
Canfield, PJ | 1 |
Okada, M | 1 |
Wakae, T | 1 |
Zouhair, A | 1 |
Weber, D | 1 |
Belkacémi, Y | 1 |
Ketterer, N | 1 |
Villà, S | 1 |
Scandolaro, L | 1 |
Bieri, S | 1 |
Studer, G | 1 |
Delacretaz, F | 1 |
Girardet, C | 1 |
Mirimanoff, RO | 1 |
Ozsahin, M | 1 |
Wilder, DD | 1 |
Ogden, JL | 1 |
Jain, VK | 1 |
Ingram, RM | 1 |
Williams, ME | 1 |
Fintel, WA | 1 |
Ross, M | 2 |
Dimopoulos, MA | 1 |
Mellou, S | 1 |
Tsatalas, C | 1 |
Papadopoulos, A | 1 |
Papageogriou, E | 1 |
Papasavvas, P | 1 |
Morschauser, F | 1 |
Marit, G | 1 |
Casasnovas, O | 1 |
Reman, O | 1 |
Molina, T | 1 |
Baiocchi, OC | 1 |
Navajas, EV | 1 |
Duarte, LC | 1 |
Alves, AC | 1 |
Andrade, AL | 1 |
Kerbauy, J | 1 |
Oliveira, JS | 1 |
Klener, P | 1 |
Donner, L | 1 |
Bowles, CA | 1 |
Lucas, D | 1 |
Graw, RG | 1 |
Tigges, FJ | 1 |
Schmülling, RM | 1 |
Hiller, E | 1 |
Waller, HD | 1 |
Wilms, K | 1 |
Mattsson, W | 1 |
von Eyben, F | 1 |
Turesson, I | 1 |
Landberg, TG | 1 |
Håkansson, LG | 1 |
Möller, TR | 2 |
Mattsson, WK | 1 |
Johansson, BG | 1 |
Killander, DC | 1 |
Molin, BF | 1 |
Westling, PF | 1 |
Lenner, PH | 1 |
Dahl, OG | 1 |
Shramko, AF | 2 |
Poddubnaia, IV | 2 |
Farr, MJ | 1 |
Newling, DW | 1 |
Raper, C | 1 |
Turner, A | 1 |
Lenhart, JE | 1 |
Yoshikawa, S | 1 |
Persohn, LK | 1 |
Drewinko, B | 1 |
Loo, TL | 1 |
Schuler, D | 1 |
Koós, R | 1 |
Révész, T | 1 |
Virág, I | 1 |
Gálfi, I | 1 |
Clarke, PR | 1 |
Saunders, M | 1 |
Exss, R | 1 |
Weber, HP | 1 |
Aungst, CW | 1 |
Mittelman, A | 1 |
Murphy, GP | 1 |
Kónyves, I | 1 |
Lindberg, G | 1 |
Berg, M | 1 |
Wilander, E | 1 |
Eriksson, A | 1 |
Pichert, G | 1 |
Peters, J | 1 |
Stahel, RA | 1 |
Dommann, C | 1 |
Joss, R | 1 |
Gebbers, JO | 1 |
Kroner, T | 1 |
Sulser, H | 1 |
Honegger, HP | 1 |
Maurer, R | 1 |
Joensuu, H | 1 |
Turpeenniemi-Hujanen, T | 1 |
Kuzuyama, Y | 1 |
Sonoda, Y | 1 |
Okuda, T | 1 |
Takashima, T | 1 |
Misawa, S | 1 |
Kashima, K | 1 |
Nakagawa, H | 1 |
Fujii, H | 1 |
Moriwaki, Y | 1 |
Naka, M | 1 |
Takagi, S | 1 |
Hidaka, T | 1 |
Takahashi, S | 1 |
Hada, T | 1 |
Nishigami, T | 1 |
Higashino, K | 1 |
Korman, DB | 1 |
Snimshchikov, VA | 1 |
Kiselev, AV | 1 |
Gordina, GA | 1 |
Morozova, OV | 1 |
Gubin, AN | 1 |
Kosechkina, NA | 1 |
Maruyama, F | 2 |
Ezaki, K | 1 |
Shimizu, K | 3 |
Ino, T | 2 |
Matsui, T | 2 |
Sobue, R | 2 |
Shinkai, K | 2 |
Miyazaki, H | 1 |
Oksenjendler, E | 1 |
Gabarre, J | 1 |
Gastaldi, R | 1 |
Farcet, JP | 1 |
Thyss, A | 1 |
Raphael, M | 1 |
Damonte, JC | 1 |
Dufour, P | 2 |
Maloisel, F | 1 |
Liu, KL | 1 |
Ortiz, S | 1 |
Bergerat, JP | 2 |
Oberling, F | 2 |
Ishige, K | 1 |
Matsue, K | 1 |
Tsukuda, K | 1 |
Sakai, C | 3 |
Demina, EA | 1 |
Evtushenko, VV | 1 |
White, L | 1 |
Siegel, SE | 1 |
Quah, TC | 1 |
Wakayama, T | 1 |
Kunika, N | 1 |
Kubomatsu, Y | 1 |
Chisa, M | 1 |
Jakić-Razumović, J | 1 |
Uzarević, B | 1 |
Petrovecki, M | 1 |
Marusić, M | 1 |
Radman, I | 1 |
Labar, B | 1 |
Guerci, AP | 1 |
Burtin, P | 1 |
Mattei, S | 1 |
Matthews, JR | 1 |
Miyazaki, E | 1 |
Kanamaru, A | 1 |
Nagai, K | 3 |
Shibata, H | 1 |
Horiuti, A | 1 |
Tsubaki, K | 1 |
Yonezawa, T | 1 |
Chubachi, A | 2 |
Takatsu, H | 1 |
Yamaguchi, A | 2 |
Nishimura, S | 2 |
Nakayama, Y | 1 |
Akihama, T | 1 |
Miura, S | 1 |
Saitoh, M | 1 |
Watanuki, T | 1 |
Santarelli, MT | 1 |
Erazo, A | 1 |
Diaz Maqueo, JC | 1 |
Lluesma Goñalons, M | 1 |
Cervantes, G | 1 |
Garcia Vela, EL | 1 |
Corrado, C | 1 |
Magnasco, H | 1 |
Oguro, M | 2 |
Hiruma, K | 1 |
Asai, T | 1 |
Aotsuka, N | 1 |
Hirasawa, A | 1 |
Wakita, H | 1 |
Endoh, N | 1 |
Yoshida, S | 1 |
Kosaka, M | 1 |
Mizuguchi, T | 1 |
Miyamoto, Y | 1 |
Fuller, L | 1 |
Redman, J | 1 |
Durr, E | 1 |
Allen, P | 1 |
Holmes, L | 1 |
Santini, G | 1 |
Capnist, G | 1 |
Coser, P | 1 |
Contu, A | 1 |
Porcellini, A | 1 |
Rizzoli, V | 1 |
Sertoli, M | 1 |
Rancan, L | 1 |
Salvagno, L | 1 |
Mazza, P | 1 |
Gherlinzoni, F | 1 |
Bocchia, M | 1 |
Fiacchini, M | 1 |
Martelli, M | 1 |
Moretti, G | 1 |
Pitini, V | 1 |
Abbadessa, V | 1 |
Nakayama, S | 1 |
Yabe, H | 1 |
Loos, U | 1 |
Musch, E | 1 |
Malek, M | 1 |
Riedel, E | 1 |
Nielsen, SH | 1 |
Hasselbalch, HC | 1 |
Birgens, HS | 1 |
Thomas, DW | 1 |
Gray, W | 1 |
Tate, RJ | 1 |
Hvizdala, EV | 2 |
Berard, C | 2 |
Callihan, T | 2 |
Falletta, J | 2 |
Sabio, H | 2 |
Shuster, JJ | 2 |
Sullivan, M | 2 |
Wharam, MD | 2 |
Ba-Thike, K | 1 |
Oo, N | 1 |
Bruntsch, U | 1 |
Lötzke, E | 1 |
Oyama, A | 1 |
Suzuki, H | 1 |
Watkin, SW | 1 |
Murayama, K | 1 |
Katsumi, T | 1 |
Watanabe, K | 1 |
Konishi, K | 1 |
Lobo, AJ | 1 |
Foster, PN | 1 |
Burke, DA | 1 |
Johnston, D | 1 |
Axon, AT | 1 |
Wheeler, K | 1 |
Chessells, JM | 1 |
Shima, N | 1 |
Takouda, K | 1 |
Tada, A | 3 |
Ohnoshi, T | 4 |
Ueoka, H | 3 |
Ueno, K | 4 |
Murashima, M | 3 |
Mizuta, J | 1 |
Kimura, I | 5 |
Hepplestone, A | 1 |
Gilchrist, NL | 1 |
Dagg, JH | 1 |
Evans, IL | 1 |
Soukop, M | 1 |
Garcia, JJ | 1 |
Duclos, B | 1 |
Ieki, R | 1 |
Goto, H | 1 |
Kouzai, Y | 1 |
Morisaki, T | 1 |
Asano, S | 1 |
Shimada, K | 1 |
Sotnikov, VM | 1 |
Polianskaia, AM | 2 |
Pan'shin, GA | 1 |
Ingberman, IaKh | 1 |
Kaplanskaia, IB | 1 |
Ohtake, S | 4 |
Kanno, M | 4 |
Kondo, K | 1 |
Okafuji, K | 1 |
Kanai, M | 1 |
Butterworth, SJ | 1 |
Sakamoto, S | 1 |
Lennert, K | 1 |
Wellens, W | 1 |
Schmidt, M | 1 |
Gassel, WD | 1 |
Kolb, T | 1 |
Hässler, R | 1 |
Hara, K | 1 |
Kunii, A | 1 |
Smith, DB | 1 |
Ledermann, JA | 1 |
Boesen, E | 1 |
Begent, RH | 1 |
Rustin, GJ | 1 |
Glaser, MG | 1 |
Bagshawe, KD | 1 |
Domingo Albós, A | 1 |
Callís, M | 1 |
Juliá, A | 1 |
Vilá, J | 1 |
Zuazu, J | 1 |
Puig, J | 1 |
Petit, J | 1 |
Fernández-Sevilla, A | 1 |
Errington, RD | 1 |
Coe, MA | 1 |
Warenius, HM | 1 |
Yamazaki, H | 2 |
Nagamine, D | 1 |
Aoyama, T | 1 |
Funakoshi, S | 1 |
Isogai, Y | 1 |
Kanehira, C | 1 |
Glynne-Jones, R | 1 |
Vernon, CC | 1 |
Bell, G | 1 |
Ota, K | 1 |
Yunoki, K | 1 |
Konda, S | 1 |
Takatsuki, K | 1 |
Ichimaru, M | 1 |
Tominaga, S | 1 |
Chuang, MW | 1 |
Tzeng, CH | 1 |
Chiou, TJ | 1 |
Chiu, CF | 1 |
Liu, JH | 1 |
Chen, PM | 1 |
Brown, T | 1 |
Bennett, B | 1 |
Moore, NR | 1 |
Imura, H | 1 |
Ito, N | 1 |
Tsukasaki, K | 1 |
Momita, S | 1 |
Murata, K | 1 |
Tokunaga, S | 1 |
Kohno, T | 1 |
Itoyama, T | 1 |
Toriya, K | 1 |
Kuriyama, K | 1 |
Hirai, J | 3 |
Naito, K | 1 |
Nakamura, E | 1 |
Shinohara, M | 1 |
Kashimura, M | 1 |
Sasayama, T | 1 |
Kusano, S | 1 |
Kashimura, Y | 1 |
Wagstaff, J | 1 |
Todd, I | 1 |
Deakin, D | 1 |
Wilkinson, P | 1 |
Jones, M | 1 |
Al-Ismail, SA | 1 |
Whittaker, JA | 1 |
Gough, J | 1 |
Bird, MC | 1 |
Bosanquet, AG | 1 |
Forskitt, S | 1 |
Gilby, ED | 1 |
Tachimori, K | 2 |
Saito, Y | 2 |
Kakinoki, Y | 1 |
Maekawa, I | 1 |
Kawamura, T | 1 |
Miyake, T | 1 |
Kurosawa, M | 1 |
Okabe, M | 1 |
Kamiya, K | 1 |
Sasaki, O | 1 |
Nemoto, K | 1 |
Honma, K | 1 |
Ohnishi, Y | 1 |
Abe, A | 1 |
Camitta, BM | 1 |
Casper, JT | 1 |
Kun, LE | 1 |
Lauer, SJ | 1 |
Starshak, RJ | 1 |
Oechler, HW | 1 |
Randall, J | 1 |
Obeid, ML | 1 |
Blackledge, GR | 1 |
Namba, K | 1 |
Imashuku, S | 1 |
Arakawa, S | 1 |
Todo, S | 1 |
Esumi, N | 1 |
Shimizu, Y | 1 |
Fujiwara, F | 1 |
Tsunamoto, K | 1 |
Morioka, Y | 1 |
Fushiki, S | 1 |
Duker, JS | 1 |
Shields, JA | 1 |
Khrennikova, GIu | 1 |
Sevast'ianova, MG | 1 |
Naumova, GA | 1 |
Tachimori, Y | 1 |
Kato, H | 1 |
Watanabe, H | 1 |
Iizuka, T | 1 |
Minato, K | 1 |
Yamaguchi, H | 1 |
Mukai, K | 1 |
Kliuchanskaia, NV | 2 |
Iliukhin, AV | 2 |
Setdikov, RA | 1 |
Mustiatsé, LZ | 1 |
Korchmaru, IF | 1 |
Takeyama, H | 1 |
Yano, K | 1 |
Fukutani, H | 1 |
Watanabe, E | 1 |
Horikoshi, N | 1 |
Inagaki, J | 1 |
Inoue, K | 1 |
Imajo, K | 1 |
Mukaiyama, T | 1 |
Garg, A | 1 |
Kochupillai, V | 1 |
Ponomar'kov, VI | 1 |
Stenzel, L | 1 |
Krug, K | 1 |
Schingnitz, G | 1 |
Keidan, SE | 1 |
Maas, B | 1 |
Ruhrmann, G | 1 |
Wilmanns, W | 1 |
Gregory, MC | 1 |
Hughes, JT | 1 |
Keipert, JA | 1 |
Wishart, JM | 1 |
Cho, ES | 1 |
Connolly, E | 1 |
Porro, RS | 1 |
Garwicz, S | 1 |
Landberg, T | 1 |
Barnett, LB | 1 |
Schwartz, E | 1 |
Mansurov, AN | 1 |
Stojcevski, T | 1 |
Fröscher, W | 1 |
Vliegen, J | 1 |
Abelson, HT | 1 |
Rabstein, LS | 1 |
Obara, Y | 1 |
Sasaki, M | 1 |
Makino, S | 1 |
Garrett, MJ | 1 |
Glazebrook, GA | 1 |
el-Akkad, SM | 1 |
Shakir, MA | 1 |
Mashburn, LT | 2 |
Stevens, J | 1 |
Stevens, YW | 1 |
Hollander, VP | 2 |
Tiwari, RM | 1 |
Hill, JM | 1 |
Roberts, J | 1 |
Loeb, E | 1 |
Khan, A | 1 |
MacLellan, A | 1 |
Hill, RW | 1 |
Streliukhina, NV | 1 |
Hall, TC | 1 |
Choi, OS | 1 |
Abadi, A | 1 |
Krant, MJ | 1 |
Rossolimo, OK | 1 |
Erokhina, NM | 1 |
Marsden, JA | 1 |
Burton, AF | 1 |
Leckie, WJ | 1 |
Tothill, P | 1 |
Ambellan, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase II Trial of Rituximab and Short Duration Chemotherapy Followed by Zevalin as First-Line Treatment for Patients With Low Grade Follicular Non-Hodgkin's Lymphoma[NCT00193440] | Phase 2 | 40 participants | Interventional | 2002-04-30 | Completed | ||
Phase 3 Study of Dose-Dense Therapy Versus CHOP in Aggressive Non-Hodgkin's Lymphoma[NCT00517894] | 0 participants | Expanded Access | No longer available | ||||
The Value of Dexamethasone Versus Prednisolone During Induction and Maintenance Therapy of Prolonged Versus Conventional Duration of L-Asparaginase Therapy During Consolidation and Late Intensification, and of Corticosteroid + VCR Pulses During Maintenanc[NCT00003728] | Phase 3 | 1,500 participants (Anticipated) | Interventional | 1998-12-31 | Active, not recruiting | ||
Gem-CHOP: A Randomized Phase II Study of Gemcitabine Combined With CHOP in Untreated Aggressive Non-Hodgkin's Lymphoma[NCT00079261] | Phase 2 | 25 participants (Actual) | Interventional | 2004-01-31 | Completed | ||
A Retrospective and Prospective Observational Study Reviewing Supportive Care Management of NHL Patients Treated With CHOP-14 or 21 Chemotherapy(With or Without Rituximab) (CHOP = Cyclophosphamide, Hydroxyrubicin (Adriamycin), Oncovin (Vincristine), Predn[NCT00903812] | 1,837 participants (Actual) | Observational | 2007-02-28 | Completed | |||
Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell[NCT02916316] | 127 participants (Actual) | Observational | 2014-02-12 | Active, not recruiting | |||
Candidate Gene Polymorphisms and Response to Rituximab-CHOP in Patients With Diffuse Large Cell Lymphoma[NCT00590941] | 52 participants (Actual) | Interventional | 2005-02-28 | Completed | |||
Phase II Trial Investigating Tailoring First-Line Therapy For Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Based on Mid-Treatment Positron Emission Tomography (PET) Scan Results[NCT00324467] | Phase 2 | 150 participants (Actual) | Interventional | 2006-08-31 | Active, not recruiting | ||
A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma[NCT00775268] | Phase 1/Phase 2 | 31 participants (Actual) | Interventional | 2008-09-29 | Terminated | ||
Randomised Trial Comparing Chemotherapy Mit CHOEP (Cyclophosphamid, Doxorubicin, Vincristin, Etoposid Und Prednison) In 21-Day Intervals In Standard And Escalated Doses In Patients Aged 18-60 Years Of Age With Aggresive Non-Hodgkin-Lymphomas Favourable Pr[NCT00053768] | Phase 3 | 392 participants (Actual) | Interventional | 2002-04-30 | Completed | ||
LINFOTARGAM: First-line Treatment With Dose-dense Chemotherapy Plus Rituximab (R-CHOP/14) and Highly Active Antiretroviral Therapy (HAART) in Patients With Diffuse Large B Cell Lymphoma (DLBCL) and Infection With the Human Immunodeficiency Virus (HIV)[NCT00466258] | Phase 4 | 50 participants (Anticipated) | Interventional | 2006-10-31 | Completed | ||
Burkimab:Study Multicenter of Optimization of the Treatment of LLA-B and the Burkitt's Lymphoma in Adult Patients (From 15 Years Old)[NCT00388193] | Phase 2 | 20 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China[NCT02405676] | Phase 2/Phase 3 | 200 participants (Anticipated) | Interventional | 2015-01-31 | Active, not recruiting | ||
Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.[NCT05049473] | Phase 2 | 100 participants (Anticipated) | Interventional | 2014-01-31 | Recruiting | ||
A Prospective, Open, Randomized Controlled, Multi-center Phase III Clinical Trial Comparing High-dose Epirubicin and Standard-dose Epirubicin in R±CEOP in Newly Diagnosed Young Patients With Medium/High-risk Diffuse Large B-cell Lymphoma[NCT03151044] | Phase 3 | 408 participants (Anticipated) | Interventional | 2016-07-31 | Recruiting | ||
Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients Aged From 18 to 59 Years With Diffuse Large B-cell Lymphoma and a Age-adjusted IPI of 1.[NCT00140595] | Phase 3 | 380 participants (Anticipated) | Interventional | 2003-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Here is the number of participants with non-serious adverse events assessed by the Common Terminology Criteria for Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life-threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT00775268)
Timeframe: Date treatment consent signed to date off study, approximately 4 years, 7 months and 9 days.
Intervention | Participants (Count of Participants) |
---|---|
Participants Scanned at Baseline & After Chemotherapy | 7 |
Participants Scanned in the Evaluation of Residual Masses After Therapy | 20 |
The time to progression (defined as time in months from 3'-deoxy-3'-[18F] fluorothymidine (FLT)-scan until patient progressed) was compared between the two groups (patients with higher Maximum Standard Uptake Value (SUVmax) vs lower SUVmax, using the median SUV value). (NCT00775268)
Timeframe: up to 4.5 years
Intervention | Months (Mean) |
---|---|
Participants Scanned After Chemotherapy | 18.29 |
FLT uptake within the tumor(s) using standard uptake value (SUVmax) was compared between baseline and completion of therapy scans. (NCT00775268)
Timeframe: up to 4.5 years
Intervention | SUVmax (Mean) | |
---|---|---|
Baseline | Completion of therapy scans | |
Participants Scanned at Baseline & After Chemotherapy | 9.15 | 0.9 |
FLT uptake was calculated within malignant residual tumors versus benign lesions using maximum standard uptake value (SUVmax). (NCT00775268)
Timeframe: up to 4.5 years
Intervention | SUVmax (Mean) | |
---|---|---|
Malignant Lesions | Benign Lesions | |
Participants Scanned in the Evaluation of Residual Masses After Therapy | 5.5 | 1.7 |
After 1 hour post-injection of fluorodeoxyglucose (FDG), the maximum uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was calculated was calculated within the residual mass. The ratio between SUVmax within the residual mass and SUVmean in the pool blood was measured. (NCT00775268)
Timeframe: up to 3.5 years
Intervention | SUVmax/Tumor blood ratio (Number) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | Patient 12 | Patient 13 | Patient 14 | Patient 15 | Patient 16 | Patient 17 | Patient 18 | Patient 19 | Patient 20 | Patient 21 | |
Participants Scanned in the Evaluation of Residual Masses After Therapy | 4.6 | 8.4 | 10.1 | 3.8 | 6.9 | 6.7 | 5.4 | 4.7 | 4.6 | 10.3 | 4.8 | 3.8 | 4.0 | 6.9 | 6.4 | 15.8 | 11.2 | 2.1 | 3.8 | 3.5 | 9.1 |
The maximum uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was calculated within the residual mass at 1 h and at 2 hours post-injection of FLT. (NCT00775268)
Timeframe: up to 3.5 years
Intervention | SUV (Mean) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | Patient 12 | Patient 13 | Patient 14 | Patient 15 | Patient 16 | Patient 17 | Patient 18 | Patient 19 | Patient 20 | Patient 21 | Overall participants | |
Participants Scanned in the Evaluation of Residual Masses After Therapy at 1 Hour Post Injection | 0.7 | 2.0 | 8.9 | 1.6 | 1.3 | 7.5 | 3.4 | 1.6 | 6.5 | 2.3 | 2.5 | 2.2 | 7.6 | 4.5 | 1.9 | 3.9 | 4.7 | 7.9 | 1.1 | 1.5 | 6.4 | 3.6 |
Participants Scanned in the Evaluation of Residual Masses After Therapy at 2 Hours Post Injection | NA | 1.8 | NA | 0.8 | 7.9 | 4.6 | 3.2 | 1.2 | 6.0 | 2.0 | 2.4 | 1.5 | 7.4 | 4.2 | 1.6 | 3.6 | 4.5 | 7.9 | 1.1 | NA | 5.4 | 2.9 |
A positive malignant residual mass was defined as focal 18F- Fluorothymidine (FLT) uptake within the residual mass greater than the normal mediastinal background uptake. FLT uptake within the mass lower than the mediastinal was considered non-malignant. The positive/negative FLT uptake was correlated with biopsy results within the residual mass (presence or absence of malignant tumor cells). (NCT00775268)
Timeframe: Up to 3.5 years
Intervention | Participants (Count of Participants) | ||||
---|---|---|---|---|---|
Presence of FLT uptake | Absence of FLT uptake and FLT uptake lower than normal mediastinum | Positive Biopsy | Negative Biopsy | Biopsy not performed | |
Participants Scanned in the Evaluation of Residual Masses After Therapy | 9 | 12 | 7 | 4 | 10 |
The maximum standard uptake value (SUVmax) (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). (NCT00775268)
Timeframe: Up to 4.5 years
Intervention | SUV (Mean) | ||||||
---|---|---|---|---|---|---|---|
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Group-level (at baseline and after completion of therapy) | |
Participants Scanned After Completion of Therapy | 0.9 | 1.0 | 1.3 | 0.9 | 0.6 | 0.9 | 0.9 |
Participants Scanned at Baseline | 10.9 | 4.8 | 10.3 | 9.1 | 9.3 | 9.2 | 9.2 |
The SUVmax (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). SUVmax was calculated at baseline and after 2-cycles of therapy. (NCT00775268)
Timeframe: Up to 4.5 years
Intervention | SUVmax (Mean) | |
---|---|---|
Baseline | 2-cycles post treatment | |
Participants Scanned at Baseline, at 2 Cycles & After ChemotherapyChemotherapy | 9.15 | 1.5 |
The SUVmax (defined as radiotracer uptake in a region of interest normalized by the injected activity and body weight) was measured within the tumor(s). The SUVmax was defined as the uptake value of the hottest pixels, within a volume of interest containing the entire tumor(s). SUVmax was calculated at baseline and after completion of therapy. (NCT00775268)
Timeframe: up to 4.5 years
Intervention | Standard Uptake Value (SUV) - units (Median) | |
---|---|---|
Baseline | After completion of scan | |
Participants Scanned at Baseline & After Chemotherapy | 9.1 | 1.5 |
36 reviews available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Lipomatosis: an unusual side-effect of cytotoxic chemotherapy?
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lipomatosis; Lymphoma, Non-Hodgkin; Male; Me | 2010 |
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2002 |
[Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Topics: Adolescent; Adult; Aged; Comorbidity; Cytomegalovirus Infections; Epstein-Barr Virus Infections; Fem | 2002 |
Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2002 |
Treatment paradigms in aggressive non-Hodgkin's lymphoma in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine- | 2002 |
[Erythema nodosum association with malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Dif | 2003 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Mo | 2003 |
Primary adrenal lymphoma presenting as Addison's disease: case report and review of the literature.
Topics: Addison Disease; Adrenal Cortex Neoplasms; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe | 2004 |
Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Ther | 2004 |
The impact of conventional and high-dose therapy for lymphoma on fertility.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; | 2004 |
Testicular granulocytic sarcoma, a source of diagnostic confusion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Nucleus; Cyclophospha | 2004 |
[Case of non-Hodgkin lymphoma with acute renal failure successfully treated with chemotherapy].
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone | 2004 |
New treatment strategies for aggressive lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubi | 2004 |
Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Autoantibodies; Desmoglein 3; Desmosomes; Gingivitis; Humans; Lymphoma, No | 2006 |
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic | 2007 |
[Malignant lymphoma of the thyroid].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2007 |
CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non-Hodgkin lymphoma (meta-analysis).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non | 2008 |
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethaso | 1994 |
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 1994 |
The treatment of non-Hodgkin's lymphoma with mitoxantrone-containing regimens.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom | 1995 |
Primary lymphoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Ad | 1996 |
Malignant tumours after renal transplantation.
Topics: Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Tran | 1996 |
[Value of radiotherapy in disseminated high-grade non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, | 1997 |
Chemotherapy in patients with acquired immunodeficiency virus syndrome associated with non-Hodgkin's lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophos | 1998 |
[Treatment of lymphoma in the aged].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubi | 1998 |
[Primary MALT-type lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1998 |
Treatment of aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immunophenoty | 1999 |
[Treatment of intermediate and high grade non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2000 |
[A case of malignant lymphoma of the epididymis].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2000 |
Isolated primary non-Hodgkin's malignant lymphoma of the larynx.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Larynge | 2001 |
A systematic overview of chemotherapy effects in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2001 |
Combination chemotherapy and rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2001 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclopho | 2001 |
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Cyclophos | 2002 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protoco | 1992 |
[Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom | 1990 |
134 trials available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressi
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chem | 2013 |
Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 2016 |
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradioth | 2014 |
Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; D | 2009 |
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2009 |
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexametha | 2010 |
Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 2010 |
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2010 |
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced L | 2010 |
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxoru | 2011 |
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclophosphamide; | 2002 |
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cyclophosphamide | 2002 |
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Pro | 2003 |
Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2003 |
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2003 |
A randomized trial comparing intensified CNOP vs. CHOP in patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2003 |
Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Co | 2003 |
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administra | 2004 |
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2004 |
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2004 |
Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2004 |
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2004 |
A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2004 |
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 2005 |
Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2005 |
Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cyclophosphami | 2005 |
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disea | 2006 |
[Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2005 |
A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyc | 2006 |
Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemothe | 2005 |
Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2006 |
A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 2006 |
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Surv | 2006 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide | 2007 |
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; | 2006 |
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette | 2007 |
Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological A | 2008 |
A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2007 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxo | 2008 |
Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr | 2008 |
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromoso | 2008 |
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi | 2008 |
Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Topics: Adult; Aged; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; | 1982 |
[Results of a cooperative clinical study of leumase].
Topics: Adolescent; Adult; Aged; Asparaginase; Child; Child, Preschool; Clinical Trials as Topic; Drug Thera | 1980 |
[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
Topics: Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymph | 1981 |
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1994 |
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Ch | 1994 |
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone | 1994 |
Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 1994 |
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant | 1994 |
Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cause of | 1995 |
Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined | 1995 |
Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Di | 1995 |
MACOP-B in advanced non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamid | 1993 |
[NEO-MACOP-B chemotherapy for the treatment of advanced-stage aggressive non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1993 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone | 1993 |
[MMIP chemotherapy for the treatment of the relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifos | 1995 |
Improved treatment results of non-Hodgkin's lymphoma in children: a report from the Children's Cancer and Leukemia Study Group of Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1995 |
Mitoxantrone, chlorambucil and prednisolone in the treatment of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Humans; Lymphoma, | 1994 |
A six-drug regimen (MAPECO) for intermediate or high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1994 |
Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1994 |
Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1994 |
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1994 |
NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Heart Failure; Humans; Lymphoma, | 1993 |
[A combination chemotherapy of mitoxantrone, etoposide, carboplatin, and prednisolone (MECP) in recurrent or refractory non-Hodgkin's lymphomas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1994 |
EPIC: an effective low toxicity regimen for relapsing lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug A | 1993 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burki | 1993 |
The rationale of therapy with mitoxantrone in non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Co-operative Study Group, (NHLCSG) Italy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; | 1993 |
Anthracycline containing regimens in intermediate grade lymphoma. Italian Cooperative Study Group on Intermediate Grade Malignant Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Idarub | 1993 |
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexametha | 1996 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophos | 1995 |
P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1995 |
Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Combined Mod | 1996 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop | 1996 |
[Usefulness of THP-COPBLM therapy in elderly patients with non-Hodgkin's lymphoma].
Topics: Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclopho | 1997 |
Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose | 1996 |
The in vivo effects of interleukin-3 on histamine levels in non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Cyclophosphamide; Doxorubici | 1997 |
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Cyclophosphami | 1997 |
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphami | 1997 |
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Che | 1997 |
Weekly chemotherapy using PMitCEBO in the palliation of recurrent non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1997 |
For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Marro | 1998 |
[Treatment of children with non-Hodgkin's lymphoma with CCLSG NHL 855/890 protocols long-term outcome and incidence of secondary malignancies].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; C | 1998 |
[Results of treating patients with highly malignant non-Hodgkin's lymphomas; comparison of treatment efficacy with CHOP and CBVPM-AVBP].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Fr | 1998 |
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Resp | 1998 |
VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1998 |
Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Granulocyte Colony- | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkyla | 1998 |
The VIM3-AraC regimen followed by autologous stem cell transplantation in refractory or relapsing aggressive non-Hodgkin's lymphoma. A prospective study of 71 consecutive cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytara | 1999 |
A phase-II study with idarubicin, etoposide and prednisone (IVPP), in patients with refractory or early relapsed intermediate or high grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Idarubicin; | 1999 |
Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin | 1997 |
A pilot study of a response oriented chemotherapeutic regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Chi | 1999 |
CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineo | 1999 |
CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1999 |
Epic as an effective, low toxicity salvage therapy for patients with poor risk lymphoma prior to beam high dose chemotherapy and peripheral blood progenitor cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; | 1999 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distr | 2000 |
Mobilization of peripheral blood stem cells by granulocyte-colony stimulating factors: comparison of a standard dose of glycosylated and mutated granulocyte-colony stimulating factor in non-Hodgkin's lymphoma patients following CHOP therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Studies; Cyclophosphamide; D | 2000 |
CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study. The Adult Lymphoma Treatment Study Gr
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxo | 2000 |
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 2001 |
Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; | 2001 |
[Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
Topics: Aged; Alopecia; Anorexia; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemo | 2001 |
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human; Cyclopho | 2001 |
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease | 2001 |
Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Admi | 2001 |
Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; De | 2002 |
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols | 2002 |
Factors predictive of early death in patients receiving high-dose CHOP (ACVB regimen) for aggressive non-Hodgkin's lymphoma: a GELA study.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cy | 2002 |
A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
Topics: Adolescent; Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid; | 1977 |
CVP-remission-maintenance in stage I or II non-Hodgkin's lymphomas: preliminary results of a randomized study.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Fema | 1979 |
Treatment of chronic lymphocytic leukemia and lymphosarcoma with a new chlorambucil ester of prednisolone (Leo 1031) (NSC-134087).
Topics: Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; P | 1975 |
MACOP-B regimen in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1992 |
Non-Hodgkin's lymphomas in children. II. Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Clinical Protoco | 1992 |
Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1992 |
[Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
Topics: Aclarubicin; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Et | 1992 |
Results of a randomized study of previously-untreated intermediate and high grade lymphoma using CHOP versus CNOP.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Do | 1992 |
Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; C | 1991 |
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1991 |
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Cyt | 1991 |
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1991 |
Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlora | 1991 |
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Re | 1990 |
Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1990 |
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resi | 1989 |
CHOP-VP16 chemotherapy and involved field irradiation for high grade non-Hodgkin's lymphomas: a phase II multicentre study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Deltaret | 1988 |
[A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV].
Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubi | 1988 |
Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine | 1988 |
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1987 |
Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical | 1987 |
[Mitoxantrone-containing combination chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophospham | 1986 |
[Clinical study of non-Hodgkin's lymphoma--results of the Kanazawa University-Kurume University Cooperative Study on Malignant Lymphomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubic | 1986 |
310 other studies available for prednisolone and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Cyclophosphamide; Di | 2020 |
Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Immunological; Ant | 2021 |
[Pyoderma gangraenosum after implantation of a shoulder endoprothesis].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Arthroplasty, Replacemen | 2017 |
Demographics and Outome in Paediatric Non-Hodgkin Lymphoma: Single Centre Experience at The Children Hospital Lahore, Pakistan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschoo | 2018 |
[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protoc | 2018 |
Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Lymp | 2018 |
Orbital richter syndrome.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, | 2013 |
Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP.
Topics: Antibodies, Monoclonal, Murine-Derived; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; | 2014 |
Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Prot | 2014 |
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2014 |
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined | 2014 |
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl | 2014 |
Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2015 |
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocol.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Anti | 2016 |
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha | 2015 |
Granulocyte growth factor use in elderly patients with non-Hodgkin's lymphoma in the United States: adherence to guidelines and comparative effectiveness.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Febrile Neutrop | 2016 |
Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: a rare disease entity.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Campylobacter Infection | 2015 |
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2008 |
Clinical investigations in aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti | 2008 |
Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cost-Benefit Analy | 2009 |
Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2009 |
[Primary non-Hodgkin lymphoma of the sternum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Human | 2009 |
Vesiculo-bullous dermatomyositis: report of three cases.
Topics: Anti-Inflammatory Agents; Breast Neoplasms; Dermatomyositis; Fatigue; Female; Follow-Up Studies; Hum | 2009 |
Bilateral low-grade B-cell lymphoma of the breast: a case report with cytological, histological and immunohistochemical studies.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Biopsy, Fine-Needle; Breast; C | 2009 |
[A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineo | 2009 |
Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspartate-Ammonia Ligase; Fatal | 2009 |
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2009 |
CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Connective Tissue Diseases; Cyclophosp | 2009 |
Generalized eruptive lentiginosis induced by chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Eruptions | 2010 |
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Et | 2010 |
The 51st annual meeting of the American Society of Hematology.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2010 |
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxo | 2011 |
Lymphoma of the cavernous sinus mimicking Tolosa-Hunt syndrome in a child.
Topics: Brain Neoplasms; Cavernous Sinus; Child, Preschool; Diagnosis, Differential; Humans; Lymphoma, Non-H | 2010 |
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabi | 2010 |
Continual reassessment method with multiple toxicity constraints.
Topics: Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bo | 2011 |
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study.
Topics: Aged; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols | 2011 |
Disseminated cryptococcosis in a non-Hodgkin's lymphoma patient with late-onset neutropenia following rituximab-CHOP chemotherapy: a case report and literature review.
Topics: Aged; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Comb | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Che | 2012 |
Mediastinal huge non-Hodgkin's lymphoma causing compression of the main pulmonary artery trunk.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Coronary Stenosis; | 2012 |
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP.
Topics: Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cycl | 2013 |
[Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas].
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Therapy, Combination; Female; Hu | 2012 |
CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 2002 |
Dose density and dose intensity: where does CHOP go from here?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; | 2002 |
Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relatio | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cy | 2002 |
Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Costs | 2002 |
Autologous stem-cell transplantation as a component of initial treatment for poor-risk patients with aggressive non-Hodgkin's lymphoma: resolved issues versus remaining opportunity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase III a | 2002 |
Coeliac disease following high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Celiac Disease; Cisplatin; Cyclophosphami | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Presch | 2003 |
Salvage surgery for primary non-Hodgkin's lymphoma of the thyroid gland with histopathological complete response to radio-chemotherapy: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosph | 2003 |
Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Protocols; Blotting, Southern; Case-C | 2003 |
[Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomark | 2003 |
Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop | 2003 |
[Successes and hazards of highdosage cortisone (prednisolone) therapy of blood diseases].
Topics: Cortisone; Hematologic Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgk | 1962 |
Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliferative disorders.
Topics: Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders | 1962 |
[On the combined therapeutic use of a corticoid and an anabolic steroid].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Anemia; beta-Thalasse | 1962 |
STEROID THERAPY IN LYMPHOID TUMOURS.
Topics: Betamethasone; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Large B-Cell, Diff | 1963 |
A CASE OF LYMPHOSARCOMA ASSOCIATED WITH MYOPATHY.
Topics: Axilla; Biopsy; Lymphoma; Lymphoma, Non-Hodgkin; Muscular Diseases; Neoplasms; Pathology; Prednisolo | 1964 |
ATRIOVENTRICULAR DISSOCIATION IN A CASE OF RETICULOSARCOMATOSIS AND THE EFFECTS OF STEROID AND CO60 IRRADIATION.
Topics: Cobalt Isotopes; Electrocardiography; Heart Block; Heart Neoplasms; Humans; Leukemia; Lymphoma, Larg | 1964 |
THE MANAGEMENT OF MALIGNANT GRANULOMA.
Topics: Diagnosis; Diagnosis, Differential; Granuloma; Granulomatosis with Polyangiitis; Hodgkin Disease; Hu | 1964 |
[THE RETICULO-ENDOTHELIAL SYSTEM AND LYMPHOSARCOMAS].
Topics: Adolescent; Adrenal Cortex Hormones; Geriatrics; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follic | 1964 |
[LEUKEMIC RETICULO-SARCOMATOSIS FOLLOWING METHYLTESTOSTERONE AND PREDNISOLONE TREATED PANMYELOPATHY AND THROMBOCYTOPENIA].
Topics: Bone Marrow Diseases; Child; Drug Therapy; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non- | 1964 |
PREDNISOLONE SENSITIVITY AND CYTOLOGY OF VIABLE LYMPHOCYTES AS TESTS FOR CHRONIC LYMPHOCYTIC LEUKEMIA.
Topics: Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphocytes; Lymphocyt | 1964 |
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA.
Topics: Adrenocorticotropic Hormone; Amphotericin B; Blood Transfusion; Bone Marrow Examination; Drug Therap | 1965 |
Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2003 |
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo | 2003 |
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Te | 2003 |
Urinary immunocytology for primary bladder B cell lymphoma.
Topics: Aged; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocy | 2004 |
Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with non-Hodgkin's lymphoma: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Edema; F | 2004 |
[Salvage combination chemotherapy with cytarabine, carboplatin and steroids for relapsed or refractory non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Administration | 2004 |
Outcome analysis for stage IE and IIE thyroid lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 2004 |
Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4-Posit | 2004 |
Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma.
Topics: Adult; Anemia, Hemolytic; Antineoplastic Agents, Hormonal; Autoimmune Diseases; Combined Modality Th | 2004 |
Time course of urinary neopterin in a non-Hodgkin's lymphoma patient during chemotherapy and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Combined Modal | 2004 |
The limits of limited stage lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non | 2004 |
[Alveolar hypoxemic interstitial pneumonia related to rituximab therapy].
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murin | 2004 |
Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; | 2004 |
Non-Hodgkin's lymphoma following treatment of atopic eczema with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Cyclosporine; Der | 2004 |
Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2004 |
[Case of obstructive jaundice as initial manifestation of non Hodgkin lymphoma in patient followed as chronic hepatitis C].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic | 2004 |
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineo | 2004 |
Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antig | 2004 |
Non-Hodgkin's lymphomas at Kenyatta the National Hospital Nairobi in the 1990's.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fe | 2004 |
Effective treatment of indolent non-hodgkin's lymphomas with mitoxantrone, chlorambucil and prednisone.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Di | 2005 |
[Use of fludarabin in conjunction with other cytostatics in the treatment of non-Hodgkin lymphoma resistant to standard chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration S | 2004 |
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2005 |
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamid | 2005 |
Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair | 2005 |
Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Biopsy; Cryptogenic Organizing Pneum | 2005 |
[Non-Hodgkin malignant lymphoma of rib origin: report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyc | 2005 |
Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Chromosomes, | 2007 |
Fatal interstitial pneumonitis related to rituximab-containing regimen.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2006 |
Chemotherapy in the management of advanced gastointestinal non-Hodgkin's lymphoma complicated with entero-cutaneous fistula: a case report.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Gastrointestinal Neoplasms; Glucocortic | 2005 |
High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2006 |
Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabi | 2006 |
Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; D | 2006 |
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D | 2007 |
Essential thrombocythemia after treatment of non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non | 2007 |
Multidrug resistance in lymphoma: is it time for clinical trials?
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, | 2007 |
Granulocytic sarcoma in the absence of acute myeloid leukemia: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Diagno | 2007 |
Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X | 2008 |
Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2008 |
Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Antineoplastic Combined Chemother | 2007 |
Vulvar metastasis as the initial presentation of non-Hodgkin's lymphoma: a case report.
Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Bartholin's G | 2007 |
Rituximab in the treatment of primary bilateral adrenal lymphoma with adrenal crisis.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal | 2008 |
[Effect of corticoids on the activity of glucose-6-phosphate dehydrogenase in erythrocytes].
Topics: Adolescent; Child; Child, Preschool; Cortisone; Erythrocytes; Female; Glucosephosphate Dehydrogenase | 1967 |
[Therapy of non-Hodgkin lymphomas of a high degree of malignancy].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma; Lympho | 1981 |
[2 cases of successful treatment of gastric lymphoma by means of polychemotherapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fema | 1984 |
[Results of treatment of patients with lymphosarcoma according to the ACVP regimen].
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclop | 1983 |
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group).
Topics: Adolescent; Adult; Aged; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Femal | 1980 |
Lactate dehydrogenase levels during MACOP-B chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cyclophosphamide; Doxo | 1993 |
[Effect of combination chemotherapy for elderly patients with malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1993 |
[Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen].
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosph | 1993 |
[VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Fema | 1994 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosp | 1994 |
Intrapleural bleomycin in the treatment of chylothorax.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chylothorax; Cyclo | 1994 |
Central nervous system lymphomas: progress in chemotherapy and radiotherapy.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Clinical Trials, Phase | 1995 |
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marr | 1995 |
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine | 1995 |
A case of non-Hodgkin's lymphoma presenting with polyuria and acute renal insufficiency.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclopho | 1995 |
Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hum | 1993 |
Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Le | 1993 |
Hepatitis after withdrawal of chemotherapy in a patient with chronic hepatitis B.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Eto | 1993 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1993 |
Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Epirubicin; Fem | 1995 |
Pemphigus foliaceus and non-Hodgkin's lymphoma.
Topics: Allopurinol; Chlorambucil; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Humans | 1994 |
Aggressive non-Hodgkin's lymphoma in elderly patients: where to go from here?
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Su | 1994 |
Avascular necrosis of bone following intensified steroid therapy for acute lymphoblastic leukaemia and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Dexamethasone; Humans; Knee Joint; Lymphoma, Non-Hodgkin; Magnetic Resonance Imag | 1994 |
[Mycotic retrobulbar neuritis].
Topics: Aged; Anemia, Aplastic; Diagnosis, Differential; Female; Humans; Lymphoma, Non-Hodgkin; Opportunisti | 1994 |
[Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1993 |
[A case of malignant lymphoma of the thyroid accompanied by interstitial pneumonitis during radiation therapy after systemic chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration S | 1994 |
[A comparative study of VEPA and ACOMEP-BD regimen for the patients with non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr | 1993 |
[Malignant lymphoma following operation and chemotherapy of small cell lung carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclo | 1993 |
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Immuno | 1993 |
Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; | 1993 |
Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; | 1995 |
[Autologous bone marrow transplantation as early therapy for patients with aggressive non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxor | 1996 |
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional C | 1996 |
Bulky centroblastic non-Hodgkin's lymphoma of the cranium vault mimicking brain involvement managed with chemotherapy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide; Diagnosis, Differ | 1995 |
Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 1996 |
[Complete regression of cardiac non-Hodgkin's lymphoma after 23 months with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Echocardiography; Electrocardiogra | 1996 |
Minor changes on cranial MRI during treatment in children with acute lymphoblastic leukaemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Child; Child, Presc | 1996 |
[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Hodgkin Disease; | 1995 |
[New approach to the treatment of primary malignant non-Hodgkin's lymphoma of the stomach].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Ant | 1996 |
[The combined chemoradiotherapy of lymphosarcomas].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham | 1995 |
Therapy-related leukemia with a novel 21q22 rearrangement.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 21; | 1996 |
[Secondary non-Hodgkin lymphoma of the prostate: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphom | 1996 |
[Chemotherapy for two patients with non-Hodgkin's lymphoma in hemodialysis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum | 1996 |
Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; D | 1996 |
[Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1996 |
F wave studies after intrathecal methotrexate administration.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Drug Therapy, Combination; Humans; Inj | 1996 |
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophos | 1996 |
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1996 |
Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: usefulness of local and regional irradiation and reduced dose chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1997 |
Synchronous oesophageal carcinoma with non Hodgkin's lymphoma, problems with management.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; | 1996 |
Malignant lymphoma of the mandible: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 1997 |
Childhood cancer and hypercalcemia: report of a case treated with pamidronate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Child, Preschool; Diphosphonates; Glucoc | 1997 |
Primary non-Hodgkin's lymphoma of the maxillary sinus.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 1997 |
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P | 1996 |
[Primary extranodal non-Hodgkin's lymphoma of muscle tissue].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Extremities; Female; Follow- | 1997 |
Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1997 |
Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hu | 1998 |
Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; C | 1998 |
Diagnosis and treatment of malignant lymphoma of the parotid gland.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclopho | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etop | 1998 |
A cyclophosphamide-induced autoimmune diabetes.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytog | 1998 |
[A case of primary malignant lymphoma of the bladder].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administr | 1998 |
Cell cycle dependency of 67gallium uptake and cytotoxicity in human cell lines of hematological malignancies.
Topics: Antineoplastic Agents; Biological Transport; Cell Cycle; Cell Division; Dose-Response Relationship, | 1998 |
[Therapy-related MDS/leukemia carrying dup(11) (q21q23) with MLL gene tandem duplication].
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Ch | 1998 |
High-grade non-Hodgkin's lymphoma treated in northern Norway--treatment, outcome, and prognostic factors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined | 1999 |
Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Granuloma; Humans; Lymphoma, Non-Hodgkin; | 1999 |
Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1999 |
Dose-escalation of CHOP in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1999 |
Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; H | 1999 |
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther | 1999 |
Nephrostomy failure due to tumour lysis syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Cyclophosphamide; Doxorubi | 2000 |
Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy, Needle; Daunorubicin; E | 2000 |
Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophospham | 2000 |
Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Central Nervous System | 2000 |
Secondary cutaneous infiltration in B cell chronic lymphocytic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Histidi | 2000 |
Renal relapse in bilateral synchronous testicular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2000 |
Primary non-Hodgkin's lymphoma of the vagina.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Sur | 2000 |
[Treatment and prognosis of children with relapsed non-Hodgkin's lymphoma--a report from CCLSG-NHL 890 Study. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 2000 |
Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2001 |
[High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Et | 2001 |
[Testicular malignant lymphoma: report of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Doxo | 2001 |
Patterns of chemotherapy administration in patients with intermediate-grade non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-F | 2001 |
CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell | 2001 |
[Angioendotheliomatosis proliferans systematizata].
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic | 2001 |
Ga-67 scintigraphy in patients with breast lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ci | 2002 |
[Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa | 2001 |
A prolonged APTT in a patient with a low grade malignant NHL - a case report.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Coagulation Factors; C | 2002 |
Therapy for Australian cats with lymphosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cat Diseases; Cats; Cohort St | 2001 |
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabin | 2002 |
Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2002 |
Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Ly | 2002 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Com | 1977 |
Immunologic studies of canine lymphosarcoma: mixed leukocyte reactivity following chemotherapy.
Topics: Animals; Asparaginase; Cyclophosphamide; Dog Diseases; Dogs; Drug Therapy, Combination; Lymphocyte C | 1978 |
[Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
Topics: Adult; Cyclophosphamide; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Dif | 1977 |
Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
Topics: Bone Marrow; Chlorambucil; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; M | 1978 |
[Results of treatment of lymphosarcoma according to the CVP program].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Drug Thera | 1978 |
Simple chemotherapy for bladder lymphoma with bilateral hydronephrosis.
Topics: Chlorambucil; Humans; Hydronephrosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Urinar | 1978 |
Obstructed uropathy treated by chemotherapy.
Topics: Allopurinol; Cyclophosphamide; Female; Humans; Lymph Node Excision; Lymphoma, Non-Hodgkin; Middle Ag | 1979 |
[Combination chemotherapy with vincristine, cyclophosphamide, procarbazine and prednisolone in advanced reticulum cell sarcoma (author's transl)].
Topics: Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Mal | 1976 |
Uptake of 1-beta-D-arabinofuranosylcytosine and prednisolone by synchronized human lymphoma cells.
Topics: Cell Division; Cell Line; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Prednisolone | 1976 |
L-asparaginase therapy and its complications in acute lymphoid leukaemia and generalized lymphosarcoma.
Topics: Adolescent; Anaphylaxis; Asparaginase; Child; Child, Preschool; Confusion; Daunorubicin; Female; Hal | 1976 |
Steroid-induced remission in spinal canal reticulum cell sarcoma. Report of two cases.
Topics: Adolescent; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; | 1975 |
[Reticulosarcoma-like skin lesions in phenylketonuria (author's transl)].
Topics: Biopsy; Child; Child, Preschool; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Phenyl | 1975 |
Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
Topics: Adult; Aged; Bone Marrow; Chlorambucil; Drug Evaluation; Drug Therapy, Combination; Esters; Female; | 1975 |
Mediastinal lymphosarcoma simulating pericarditis.
Topics: Child; Diagnosis, Differential; Diseases in Twins; Heart Neoplasms; Humans; Lymphoma, Non-Hodgkin; M | 1975 |
Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1992 |
[Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophos | 1992 |
Malignant lymphoma in the mesentery with immune thrombocytopenia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Immunogl | 1992 |
[A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chylothorax; Cyclophosphamide; Female; Humans; Lymph | 1992 |
[Lymphosarcoma of the stomach in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Child; Combined Modality | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclo | 1992 |
Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Ly | 1992 |
Fulminant hepatic failure in non-Hodgkin lymphoma patients treated with chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Li | 1992 |
[Treatment of elderly patients with hematological malignancies].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit | 1992 |
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamid | 1992 |
[THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1992 |
[The use of novantrone in combination with other preparations in hematosarcoma patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, La | 1992 |
AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cyclophosphamide; DNA, Neoplasm; Doxorub | 1992 |
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunos | 1992 |
[A retrospective comparison study of patients old and young with non-Hodgkin's lymphoma].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Res | 1992 |
[Combination chemotherapy (modified CHOP-Bleo) in non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1990 |
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C | 1990 |
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci | 1991 |
[The results of the combined chemoradiation treatment of lymphosarcomas corresponding to the degree of its intensity].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1991 |
[Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycl | 1991 |
[Metabolic disorders in the treatment of malignant hematologic diseases--the acute tumor lysis syndrome].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; | 1991 |
Non-Hodgkin's lymphoma presenting at the site of a recent dental extraction: a report of two cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Humans; Jaw Neoplasms; Ly | 1991 |
Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1991 |
Non-Hodgkin's lymphoma in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Female; Fetus | 1990 |
Non-Hodgkin's lymphoma. A four-drug regimen suitable for elderly patients with advanced disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Evaluation; Female; Humans; | 1990 |
[Primary malignant lymphoma of the urinary bladder: report of a case].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality Therapy; Cyc | 1990 |
Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1990 |
The role of azathioprine in the management of ulcerative colitis.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; M | 1990 |
UKALL X--an effective treatment for stage III mediastinal non-Hodgkin's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; D | 1990 |
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined M | 1990 |
Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Resp | 1990 |
[Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 1990 |
[Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide | 1987 |
Failure of conventional chemotherapy in aggressive lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici | 1987 |
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; | 1989 |
Endobronchial non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Cyclophosphamide; Do | 1989 |
[Chemoradiation treatment of patients with aggressive non-Hodgkin's lymphomas in stages I to II of the disease].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; | 1989 |
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; | 1989 |
Resolution of lymphosarcoma associated blindness in a dog following chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Dog Diseases; | 1989 |
Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; D | 1989 |
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposid | 1989 |
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug | 1989 |
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; D | 1989 |
[Adjuvant chemotherapy for stage I and II non-Hodgkin's lymphoma--a seven-year follow up].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 1989 |
Is steroid psychosis preventable by divided doses?
Topics: Adult; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Psyc | 1986 |
[A comparative trial of C-novantrone OP(CNOP) vs C-adriamycin OP(CHOP) in the treatment of stage II-IV malignant lymphoma--the preliminary report].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic | 1988 |
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D | 1988 |
[THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubic | 1988 |
[Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubici | 1988 |
[A primary malignant lymphoma of the vulva--a case report].
Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Combined Modality | 1988 |
[Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
Topics: Adult; Aged; Aged, 80 and over; Antigens, Differentiation; Antineoplastic Combined Chemotherapy Prot | 1988 |
Long-term comparison of results of a drug sensitivity assay in vitro with patient response in lymphatic neoplasms.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Drug Screening | 1988 |
[Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
Topics: Aclarubicin; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto | 1987 |
[Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined | 1987 |
Three cases of secondary leukemia. Clinicopathologic findings.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fema | 1987 |
Isolated bilateral T-cell renal lymphoblastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Doxorubicin; Female; Humans; Kidne | 1986 |
Haemorrhage and perforation of gastrointestinal neoplasms during chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Femal | 1986 |
[Therapeutic results in 22 cases of childhood non-Hodgkin's lymphoma treated by ACOP combination chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 1987 |
Salvage chemotherapy for non-Hodgkin's lymphoma with a combination of mitoxantrone, etoposide, cisplatin, and prednisolone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; L | 1987 |
Intraocular large cell lymphoma presenting as massive thickening of the uveal tract.
Topics: Diagnosis, Differential; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Predniso | 1987 |
[Clinico-hematological effect of spirobromin in chronic lympholeukemia amd malignant non-Hodgkin's lymphoma].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophospha | 1987 |
Mediastinal malignant lymphoma complicated with esophagobronchial fistula: successfully treated case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchial Fistula; Combined Modality Therapy | 1987 |
[Possibility of the comparative evaluation of chemotherapy effectiveness in hemoblastoses in man and dogs].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Doxor | 1986 |
[Clinical picture and treatment of lesions of the epidural space in lymphosarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Daunorubi | 1986 |
[Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Eval | 1986 |
[A preliminary study of chemo-interferon therapy in malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Adm | 1987 |
[Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophospham | 1986 |
[Salvage chemotherapy of non-Hodgkin's lymphoma with a four-drug combination of mitoxantrone, etoposide, cisplatin and prednisolone (MEPP)].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etopos | 1987 |
Non-Hodgkin's lymphoma in pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow | 1985 |
[Results of the treatment of lymphosarcoma of the large intestine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Cecum; Colectomy; Colonic Neoplasms | 1985 |
[Clinico-morphological analysis of chemotherapy effectiveness in spontaneous hemoblastoses in dogs].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dog Diseases; Dogs; Drug | 1985 |
[Results of polychemotherapy in neoplasms of the lymphoreticular system].
Topics: Antineoplastic Agents; Cyclophosphamide; Hodgkin Disease; Humans; Infections; Leukopenia; Long-Term | 1973 |
Paraplegia in childhood malignant disease.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Humans; Infant; Leukemi | 1967 |
[Adriamycin in the therapy of child leukemias and tumors].
Topics: Acute Disease; Adolescent; Doxorubicin; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neo | 1973 |
Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.
Topics: Adrenocorticotropic Hormone; Brain Neoplasms; Cerebral Ventricles; Cerebrospinal Fluid Proteins; Cra | 1973 |
Temporary resolution of geographic tongue with cytotoxic therapy.
Topics: Child; Drug Therapy, Combination; Glossitis, Benign Migratory; Humans; Lymphoma, Non-Hodgkin; Male; | 1974 |
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression.
Topics: Adult; Azathioprine; Dermatomyositis; Erythema; Female; Humans; Immunosuppressive Agents; Lymphoma, | 1973 |
Primary reticulum cell sarcoma of the brain in a renal transplantation recipient.
Topics: Abscess; Adult; Azathioprine; Brain Neoplasms; Chronic Disease; Epididymitis; Frontal Lobe; Glomerul | 1974 |
Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.
Topics: Adolescent; Bone Marrow Diseases; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Femal | 1974 |
Cerebral reticulum cell sarcoma after multiple renal transplants.
Topics: Adult; Azathioprine; Brain Neoplasms; Dactinomycin; Glomerulonephritis; Humans; Immunosuppression Th | 1974 |
[Complex treatment of reticulosarcoma and lymphosarcoma patients].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lymphoma, Non- | 1974 |
Haemolytic anaemia in malignant lymphoreticuloendothelial diseases.
Topics: Adult; Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Autoantibodies; Bone Marrow Examination; Ce | 1974 |
[Problems concerning differential diagnosis in transvers leasions of the spinal cord (author's transl)].
Topics: Adolescent; Arterial Occlusive Diseases; Cervical Vertebrae; Diagnosis, Differential; Diagnostic Err | 1973 |
Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.
Topics: Animals; Cell Transformation, Neoplastic; Depression, Chemical; Female; Leukemia, Experimental; Leuk | 1970 |
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma.
Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Chromosome Aberrations; Culture Techniques; | 1971 |
Combination chemotherapy in malignant disease.
Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem | 1971 |
Combination chemotherapy with L-asparaginase (EC-2) using P1798 lymphosarcoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cyclophosphami | 1971 |
Glucocorticoid inhibition of precursor incorporation into nuclear RNA of P1798 lymphosarcoma.
Topics: Animals; Carbon Isotopes; Cell Biology; Cell Nucleus; Centrifugation, Density Gradient; Chromatograp | 1971 |
Lymphosarcoma of lacrimal gland.
Topics: Aged; Exophthalmos; Eye Neoplasms; Female; Humans; Lacrimal Apparatus; Lymphoma, Non-Hodgkin; Predni | 1971 |
L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Child; Humans; Leukemia, Lymphoid; Leukemia, Myeloi | 1967 |
[Modern aspects of treatment of acute leukemia].
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Child; Female; Humans; Leukemia, Lymphoid | 1968 |
High-dose corticoid therapy in Hodgkin's disease and other lymphomas.
Topics: Adolescent; Adult; Aged; Cortisone; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hodgkin Di | 1967 |
[Study of combined action of bruneomycin and prednisolone on the development of mouse lymphosarcoma (strain LIO-1)].
Topics: Animals; Antibiotics, Antineoplastic; Drug Synergism; Lymphoma, Non-Hodgkin; Mice; Prednisolone | 1968 |
The management of hypercalcaemia in malignant disease.
Topics: Adult; Breast Neoplasms; Diet Therapy; Humans; Hydrocortisone; Hypercalcemia; Lymphoma, Non-Hodgkin; | 1965 |
Inhibition of 11-beta-hydroxysteroid dhydrogenase activity in rat and mouse tissues in vitro and in vivo.
Topics: Animals; Blood; Cortisone; Enzymes; Hydrocortisone; Hydroxyprogesterones; Hydroxysteroid Dehydrogena | 1965 |
Albumin turnover in pleural effusions.
Topics: Administration, Topical; Anti-Inflammatory Agents; Breast Neoplasms; Capillary Permeability; Heart F | 1965 |
The role of ribonuclease in regression of lymphosarcoma P1798.
Topics: Animals; Chloromercuribenzoates; Chromatography; Corticosterone; Fluorouracil; Freezing; Hydrocortis | 1966 |